US20100312076A1 - Pop box methods and systems for assessing risk of pressure related skin injury and determining a recommended treatment thereof - Google Patents

Pop box methods and systems for assessing risk of pressure related skin injury and determining a recommended treatment thereof Download PDF

Info

Publication number
US20100312076A1
US20100312076A1 US12/793,514 US79351410A US2010312076A1 US 20100312076 A1 US20100312076 A1 US 20100312076A1 US 79351410 A US79351410 A US 79351410A US 2010312076 A1 US2010312076 A1 US 2010312076A1
Authority
US
United States
Prior art keywords
assigning
patient
rating
responsive
receiving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/793,514
Inventor
Deborah C. Bly
Marilyn E. Schallom
Carrie Sona
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US12/793,514 priority Critical patent/US20100312076A1/en
Publication of US20100312076A1 publication Critical patent/US20100312076A1/en
Priority to US15/862,358 priority patent/US11172871B2/en
Priority to US17/526,790 priority patent/US20220071551A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/41Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/412Detecting or monitoring sepsis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/445Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/447Skin evaluation, e.g. for skin disorder diagnosis specially adapted for aiding the prevention of ulcer or pressure sore development, i.e. before the ulcer or sore has developed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6843Monitoring or controlling sensor contact pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271Specific aspects of physiological measurement analysis
    • A61B5/7275Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0247Pressure sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14542Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases

Definitions

  • the present disclosure relates to methods and systems for medical evaluation care and, more specifically, to systems and methods for evaluating a patient for pressure related skin injury risk and recommended treatment.
  • HAC hospital acquired conditions
  • POA admission
  • the current risk identification tools used most commonly for assessment of patient risk of pressure related skin injury are the Braden (copy attached as FIG. 1 by way of example) and the Norton scale (not attached). These tools have become the gold standard for basic risk assessment. However, as described herein, these tools are only the start of the necessary assessment for risk related injury as neither scale addresses the more complex components of critical illness, physiological responses and treatments. All of which have non-visible caustic potential.
  • POP Box Pressure, Oxygenation, and Perfusion (hereinafter “POP Box”) systems and methods have been created to expose and apply physiologic factors that lead to skin failure and increased risk of pressure ulcers. In general these intrinsic and/or extrinsic variables and factors have been determined by the inventor to affect pressure, oxygenation or perfusion to skin surface.
  • the POP Box as described herein builds on prior assessments and applies a variety of factors related to the integumentary system, homeostasis and physiological stressors that more fully addresses risks for each patient. The present method and system does not stop or limit itself to the prior risk factors teachings and belief that following the current care practices will prevent pressure ulcers in all cases.
  • EBM evidence based medicine
  • the POP box has been created to expose other insults to patients that can lead to skin failure. In particular, it has been created to identify the extrinsic and intrinsic patient factors leading to skin breakdown and to remove the fault of the nurse in skin injury.
  • the POP Box system and method as described herein utilize the identified variables that have been determined to affect tissue oxygenation.
  • tissue oxygenation StO2
  • the systems and methods described herein will improve the assessment of the risks and prediction of pressure related injury over prior systems and methods. This includes the determination of pressure related injury that occurs from inside the body such as from deep tissue injury, rather than externally applied as previously believed in many cases.
  • the POP Box can also be named, for example as the “Oxy Bin” illustrating the “bin” or “box” nature of considering the various oxygenation variables in an assessment system and method.
  • a system for assessing a patient for pressure related skin injury risk and recommended treatment includes a memory, an input device, an output device, and a processor.
  • the memory and processor include computer executable instructions for implementing the method of receiving a measured pressure on the skin of the patient, and assigning a rating responsive to the received pressure measurement.
  • the method also includes receiving a measured tissue oxygenation of the patient and assigning a rating responsive to the received oxygenation measurement.
  • the method further includes receiving a measured perfusion of the patient and assigning a rating responsive to the received perfusion measurement.
  • the method also includes summing the pressure, tissue oxygenation and perfusion ratings to obtain a POP Box score, determining a risk of pressure related skin injury for the patient in response to the POP Box score and determining a recommended treatment from among a plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury.
  • computer readable medium having computer executable instructions for assessing a patient for pressure related skin injury risk and recommended treatment include computer executable instructions performing the method of receiving a measured skin pressure of the patient and assigning a rating responsive to the received skin pressure measurement.
  • the method also includes receiving a measured oxygenation of the patient and assigning a rating responsive to the received oxygenation measurement.
  • the method further includes receiving a measured perfusion of the patient and assigning a rating responsive to the received perfusion measurement.
  • the method also includes summing the skin pressure, oxygenation and perfusion ratings to obtain a POP Box score, determining a risk of pressure related skin injury for the patient in response to the POP Box score. and determining a recommended treatment from among a plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury.
  • a method for assessing a patient for pressure related skin injury risk and recommended treatment includes measuring skin pressure of the patient and assigning a rating responsive to the skin pressure measurement, measuring tissue oxygenation of the patient and assigning a rating responsive to the tissue oxygenation measurement, and measuring perfusion of the patient and assigning a rating responsive to the perfusion measurement.
  • the method also includes summing the skin pressure, tissue oxygenation and perfusion ratings to obtain a POP Box score, determining a risk of pressure related skin injury for the patient in response to the POP Box score, and determining a recommended treatment from among a plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury.
  • such methods can include measuring skin pressure of the patient and assigning a rating responsive to the skin pressure measurement, measuring oxygenation of the patient and assigning a rating responsive to the oxygenation measurement, measuring perfusion of the patient and assigning a rating responsive to the perfusion measurement, summing the skin pressure, oxygenation and perfusion ratings to obtain a POP Box score, determining a risk of pressure related skin injury for the patient in response to the POP Box score, and determining a recommended treatment from among a plurality of available recommended treatments for the patient in response to the determined risk of pressure related skin injury.
  • a system or method for assessing a patient for pressure related skin injury risk and recommended treatment including measuring StO2 in the patient and assigning a first StO2 rating where StO2 levels of WNL SO2 are less than 10 percent of normal; assigning a second StO2 rating where StO2 is between 10 and 20 percent of normal; assigning a third StO2 rating where StO2 is between 20 and 30 percent of normal; and assigning a fourth StO2 rating where StO2 is greater than 30 percent of normal.
  • the method also includes summing the assigned ratings to obtain a POP Box score, and determining a risk of pressure related skin injury for the patient in response to the POP Box score, and determining or selecting a recommended treatment from among a plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury.
  • a system or method for assessing a patient for pressure related skin injury risk and recommended treatment including evaluating the patient based on a review of various factors and assigning a rating responsive to the evaluations including measuring StO2 in the patient and assigning a rating responsive to the StO2 measurement.
  • the method can also include one or more of the following additional processes: determining an age of the patient and assigning a rating responsive to the determining; determining a body mass index of the patient and assigning a rating responsive to the determining; determining whether the patient was found in a down position prior to evaluation and assigning a rating responsive to the determining; determining an operating room variable of the patient wherein in the assigning is responsive to the number of such operating room variables present; determining a presence of one or more disease processes present in the patient wherein in the assigning is responsive to the number of such disease processes are present; determining steroid use by the patient and assigning a rating responsive to the determining; determining LOS for both ICU and regular hospital stays for the patient and assigning a rating responsive to the determining; determining a pressure redistribution surface time of the patient and assigning a rating responsive to the determining; determining a presence of pain or paralysis of the patient and assigning a rating responsive to the determining; measuring a vital sign of the patient including the blood pressure and
  • FIG. 1 is a chart of a Braden Scale for Predicting Pressure Sore Risk as currently used in the art.
  • FIG. 2 is a chart of the Pressure, Oxygenation, and Perfusion (POP) Box system and method according to one exemplary embodiment of the disclosure.
  • FIG. 3 is a block diagram of a computer system that may be used to implement one or more exemplary embodiments and/or one or more components or modules of the Pressure, Oxygenation, and Perfusion (POP) Box system and method as described herein.
  • POP Perfusion
  • FIG. 4 is a flow chart diagram of a method for assessing a patient for pressure related skin injury risk and recommended treatment according to one exemplary embodiment.
  • a system or method for assessing a patient for pressure related skin injury risk and recommended treatment including measuring skin pressure of the patient and assigning a rating responsive to the skin pressure measurement, measuring oxygenation of the patient and assigning a rating responsive to the oxygenation measurement, measuring perfusion of the patient and assigning a rating responsive to the perfusion measurement, summing the pressure, oxygenation and perfusion ratings to obtain a POP Box score, determining a risk of pressure related skin injury for the patient in response to the POP Box score, and selecting or determining a recommended treatment for the patient in response to the determined risk of pressure related skin injury.
  • skin pressure or sometimes just pressure refer to intrinsic and extrinsic forces that are applied to the skin that can result in injury to the skin resulting from such forces.
  • the process herein includes selecting and/or determining a recommended treatment
  • nothing in this present disclosure or claims specifically identifies the particular treatments based on the POP Box scores or in anyway limits or restricts those treatments.
  • the determined recommended treatments of the present systems and methods are determined using the POP Box scores from the experience of the medical care providers and by standards that can be determined overall time based on the best practices in the medical profession as determined in view of the determined POP Box scores. Such determined recommended treatments can vary by medical care provider and are expected to change over time.
  • a risk of pressure related skin injury is determined for the patient in response to the POP Box score.
  • a recommended treatment for the patient is then selected in response to the determined risk of pressure related skin injury. This later can include, but is not limited to, assigning ratings on a scale of 1 to 4 and taking no action with the POP Box score is 0 to 25, but where the POP Box score is 25 to 50, provide normal turn on redistributing surface practice, the POP Box score is 50 to 75, adapt patient care for low air loss overlay or surface with constant air redistribution, the POP Box score is between 75 and 100, provide patient with a low air loss bed, provide a more frequent turn schedule and/or continual turn bed; and where the POP Box score is greater than 100, provide patient with a low air loss bed with continual turning.
  • the method can include evaluating the patient using Braden Scale to obtain a Braden Score and assigning a rating from 1 to 4 responsive to the Braden Score.
  • the Braden Score can be included in the POP Box score for evaluation and selection of the treatment for the patient.
  • StO2 local tissue oxygen saturation
  • StO2 as a measurement of tissue oxygenation can be measured in the microcirculation where oxygen is exchanged with tissue such as by continuous measurement/monitoring of peripheral perfusion, as known to those of skill in the art.
  • the method provides for assigning a first StO2 rating where StO2 levels of WNL SO2 are less than 10 percent of normal; assigning a second StO2 rating where StO2 is between 10 and 20 percent of normal; assigning a third StO2 rating where StO2 is between 20 and 30 percent of normal; and assigning a fourth StO2 rating where StO2 is greater than 30 percent of normal.
  • StO2 monitoring becomes more widely available to medical personnel that may be due in part to its significant benefit in analyzing pressure ulcer risks
  • the variables as identified herein and their various determined numerical value assignments can provide medical care personnel with a significant improvement in medical diagnosis and improved patient care.
  • the method can include one or more of the following processes that can be included as factors in predicting pressure sore risk and in determining appropriate recommended treatments. These can include one or more of:
  • a vital sign of the patient including the blood pressure and heart rate and assigning a rating responsive to the measuring (such as heart rate (HR); Systolic blood pressure (SBP); diastolic blood pressure (DBP); and mean arterial pressure (MAP));
  • HR heart rate
  • SBP Systolic blood pressure
  • DBP diastolic blood pressure
  • MAP mean arterial pressure
  • CI Cardiac Index
  • CO Cardiac Output
  • identifying maceration that can include identifying moisture content of linens and clothing of the patient, for example, and assigning a rating responsive to the identifying;
  • the Pressure, Oxygenation, and Perfusion (POP) Box (POP Box) system and method can include all or a portion of the following evaluation factors and POP Factor Assessment Value (POP FAV) (in this example of assigning a rating from 1 to 4 for each factor). It should be understood to those skilled in the art that one or several of these factors may not be applicable to a particular patient and therefore not applicable to the current system and method, generally on a patient by patient basis.
  • POP FAV POP Factor Assessment Value
  • POP Box Factor analysis addresses 25 exemplary intrinsic and extrinsic factors, some or all of them can be included in the POP Box as may be determined suitable for particular uses and as determined overtime by a medical care practitioner. This example allocates each of these into four categories for ratings and assignment of ratings. Of course one skilled in the art will understand that a more or less granular rating assignment scheme can also be employed and still be within the scope of the present disclosure and claims.
  • a POP Factor weighting assignment includes as one factor a Braden Scale assessment having different POP Box categories allocations for factor weighting: a first for a Braden score of 17-15; a second for a Braden score of 14-12; a third for a Braden score of 12-10; and a fourth for a Braden score of 9 and below.
  • the Braden scale of FIG. 1 is a copyrighted document of Barbara Braden and Nancy Bergstrom, 1988.
  • the POP Factor B Weighting Assignment of the patient's age into the four exemplary categories can include the following, one category classification for each of: a first for an age range of 20-40 years old; a second for an age range of age 40-60 years old; a third for an age range of age 60-80 years old; and a fourth for an age of older than 80.
  • BMI Body Mass Index
  • the POP Factor for weighting assignment for the factor of the patient being found in a down position can include: a first when found down for short period of time less than 1 hour; a second when found down between 1 to 2 hours wherein the ph and lactate may/or may not be affected; a third when found down between 2 to 5 hours and wherein a ph measurement is down and lactate is identified as being elevated; and a fourth when found down greater than 5 hours and where the measured ph is down and lactate is up, with potentially MB-CPK (creatine phosphokinase-MB (CPK-MB)) is up.
  • the CPK-MB measurement is a cardiac marker often used to assist diagnoses of an acute myocardial infarction.
  • Vital signs can include the patient's heart rate (HR); Systolic blood pressure (SBP); diastolic blood pressure (DBP); and/or mean arterial pressure (MAP). This can also include instability such as Tachycardia and Hypotension. With decrease in blood pressure (B/P), it would be assumed that tissue perfusion and ultimately tissue oxygenation are effected. When increased HR atrial kick is lost, cardiac output is decreased and potential for a decrease in perfusion state exists. There is a potential for 20% of blood volume (stroke volume) to be lost. Increased skin temperature can improve perfusion but increases in temperature increases oxygen consumption. Furthermore a febrile state may increase vasodilatation and skins perfusion but rigors in this febrile state will increase oxygen consumption (VO).
  • HR heart rate
  • SBP Systolic blood pressure
  • DBP diastolic blood pressure
  • MAP mean arterial pressure
  • the POP Factor weighting assignment for measured vital signs can include an allocation to four categories, for example: a first for HR within normal levels (WNL), SBP ⁇ 90 DBP ⁇ 60, MAP ⁇ 60; a second for HR>100, SBP ⁇ 85 DBP ⁇ 50, MAP ⁇ 55; a third for HR>120, SBP ⁇ 70 DBP ⁇ 45, MAP ⁇ 50; and a fourth for HR in/out>140, SBP 70 or less with tacky: DBP and MAP critically low.
  • WNL normal levels
  • SBP ⁇ 90 DBP ⁇ 60, MAP ⁇ 60 a second for HR>100, SBP ⁇ 85 DBP ⁇ 50, MAP ⁇ 55
  • a fourth for HR in/out>140, SBP 70 or less with tacky: DBP and MAP critically low can change and the categorization made more complex with various combinations of measurements.
  • vaso active agents With the use of vaso active agents to enhance cardiac output and brain and heart perfusion, it is known that the periphery is vasoconstricted to increase cardiac return, thus, blood volume is taken from the periphery to the core. This factor addresses the caustic affects to the integument system by those known vasoconstriction agents.
  • the POP Factor weighting assignment for identified or measured pressor agents can include: a first for Dopamine at 5 mcg/kg/min or Levophed 5-10 mcg/min; a second for Dopamine 10-15 mcg/kg/min or Levophed 10-15 mcg/min; a third for Dopamine 15-25 mcg/kg/min or Levophed 15-25 mcg/min; and a fourth for Dopamine ineffective or Levophed>25 mcg/min.
  • SvO2 or ScvO2 A venous oxygen saturation (SvO2) or central venous oxygen saturation (ScvO2) represents the venous return side. Correlation of tissue oxygenation and extraction are interrelated. Poor (low or very high SvO2) can represent limited oxygen extraction. It may also represent limited oxygen carrying capacity. At this time, SvO2 is the closest number for tissue oxygenation/extraction known. Different shock states will have variable SvO2 values but are expected to have the same effect to the skin. While measurement of the change in the SvO2 is often not available due to its invasiveness, when available to be measured, it can contribute useful information regarding systemic oxygenation delivery and consumption.
  • the POP Factor weighting a for assignments for measured venous oxygen saturation (SvO2) or central venous oxygen saturation (ScvO2) can include: a first for a measured SvO2 ⁇ 60 or >75; a second for a measured SvO2 of 40-50 cardiogenic/75-80 septic shock; a third for a measured SvO2 ⁇ 40 cardiogenic/80-90 septic shock; and a fourth for a measured SvO2 ⁇ 30 cardogenic shock/>90 septic shock.
  • P/F Ratio The ratio of arterial oxygen concentration to the fraction of inspired oxygen (P/F ratio) can also be a factor as a decreasing P/F ratio, e.g., PaO2/FiO, may indicate the capability to upload oxygen to hemoglobin is affected. Therefore, P/F ratio measurement can assist with assessment of factors affecting oxygenation at all levels.
  • the POP Factor weighting assignment for the P/F Ratio can include: a first for a P/F ratio 280-250; a second for a P/F ratio 250-200; a third for a P/F ratio 200-150; and a fourth for a P/F ratio of less than 150.
  • the POP Factor weighting assignment for SpO2 can include: a first for a recovery time of 1-2 minutes; a second for a recovery time of 2-5 minutes; a third for a recovery time of 5-10 minutes; and a fourth for a recovery time of greater than 10 minutes
  • J. CO/CI/SV With the decrease in cardiac function tissue, perfusion is affected, thus tissue oxygenation. Evaluation of the cardiac output, the cardiac index and/or the stroke volume (SV) can be indicative and instructive. Poor EF and Poor SV will result in a decrease in distal tissue perfusion. As CI goes down, the Stroke Volume (SV) will increase thus potentiating decreased tissue oxygenation at peripheral locations.
  • the POP Factor weighting assignment for Cardiac Output (CO) and/or Cardiac Index (CI) can include: a first for CI-2.5 BNP>100 or SV>60; a second for CI ⁇ 2.0 BNP>200 or 60 ⁇ SV>55; a third for CI ⁇ 1.5 BNP>500 or 55 ⁇ SV>50; and a fourth for CI ⁇ 1.0 BNP>800 or SV ⁇ 50.
  • the massive edema can include—Sepsis fluid resuscitation, acute renal failure (ARF), and low albumin.
  • ARF acute renal failure
  • the body's homeostatic mechanisms lead to fluid retention.
  • the body can swell more that 4 + anascarca by retaining extra fluids.
  • the body can hold liters of extra fluid and stretch the integumentary system that can result in cracking and blistering of the skin.
  • weeping will start and constant moisture expulsion will ensue. Additionally, maceration and deterioration to the skin will happen.
  • both albumin and oncotic pressure are low, fluid shifts to a third space.
  • the POP Factor weighting assignment for edema can include: a first for Edema considered to be +1 mm with finger compression; a second for Edema considered to be +2 mm with finger compression; a first for Edema considered to be +3 mm with finger compression; and a fourth for Edema considered to be +4 or greater with finger compression.
  • the POP Factor weighting assignment for the operating room procedures can include: a first where 1-2 variables are present or identified; a second wherein 3-4 variables are present; a third where 5-6 variables are present; and a fourth where there are 7 or more variables present.
  • ER Time A patient can have an extensive stay while awaiting treatment and a room. Often there is no pressure redistributing device either for chairs or stretchers. Additionally, trauma patients are on a hard backboard. As a result, the amount of time until treatment needs to be considered.
  • the POP Factor weighting assignment for ER time can include: a first for an ER time of 4-6 hours or less; a second for an ER time of 6-10 hours; a third for an ER time of between 11-20 hours; and a fourth for an ER time greater than 20 hours.
  • the POP Factor weighting assignment for patient apparatus can include: a first for one apparatus variable being present; a second where there are 2 apparatus variables present; a third where there are 3 apparatus variables present; and a fourth where there are 4 or more variables present.
  • O. Disease Process The reality of underlying disease process effecting perfusion and oxygenation is not accounted for with current risk assessment tools. With the advent of deep tissue injury (NPUAP) the understanding that injury can occur from the inside out is now understood. It has been determined that there are diseases that predispose skin to injury more quickly. Those that involve decrease perfusion and oxygenation at the tissue level are considered as such, but also can include those that involve decreased sensory and movement capability including those having a neurological effect.
  • the possible disease process factors or variables can include: a. CAD: decreased perfusion systemically and peripherally; b. DM: vascular changes; c. CHF, CM: Decreased perfusion, vascular stress; d. COPD: Smoker-vascular, oxygenation and ventilation effect; e.
  • Pulm HTN decreased oxygenation, possible right to left heart shunt-decreased SaO2, potentially all pulmonary diseases to be added: IPF, CF, by ways of example. All that affects oxygenation (decreased P/F ratios); f. Vascular dx: PVD; g. Autoimmune: Vascular collagen changes at a micro vascular level; h. CF: decreased oxygenation at pulmonary level e.g., a decreased SaO2; i. Physical components: micro emboli, nail clubbing; j. PE: oxygenation effect-P/F ratio overlap; k.
  • Renal Failure low epogen, low O2 carrying capacity, and/or sudden changes to periphery such as changes in MAP with hemodyalysis or CVVHD; 1.
  • ESLD decreased albumin production, decreased oncotic pressures, decreased gluconeogenisis, decreased collagen production. Increased ascites accumulation and fluid shifts. Pleural effusion that can affect oxygenation. Edema effecting stress and tension on skin. A patient with lower B/P in general therefore with decreased MAP effecting decreased perfusion.
  • the POP Factor weighting assignment can include: a first where one variable are present; a second where 2 variables are present; a third where 3 variables are present; and a fourth where 4 or more variables are present.
  • P. Steroids With vascular compromise the body mounts an inflammatory response to help bring added nutrition and vascular elements to the affected area. With chronic immunosuppression, the body is unable to mount the natural inflammatory response for wound healing. With chronic steroid use there is also a decrease of Estrogen production that causes a decrease in collagen production and its protective layer at the subcutaneous layer.
  • the POP Factor weighting assignment to consider the patient's use of steroids can include: a first category for one time yearly use for control of a disease process; a second for two times yearly with disease flare; a third for daily use with disease control; and a fourth where daily use with disease process not controlled.
  • the POP Factor weighting assignment for identification of maceration can include: a first where linens or clothing moisture are saturated q8 hours; a second for linen change required q4 hours; a third for linens changed q2 to maintain skin dryness; and a fourth where it is not possible to fully stop constant moisture i.e., greater that +4 edema that has stretched and is now constantly leaking fluids due to impaired integumentary
  • Blood Glucose Cellular activity is most functional when availability of Insulin for cellular activity (enzymatic transport) is kept at appropriate levels. Insulin being the most important factor for active transport in blood glucose (BG) utilization.
  • BG blood glucose
  • Well balanced glucose control facilitates ATP synthesis, thus providing necessary factors for protein utilization, cellular response to stress i.e., inflammatory process and aiding in the healing process. (Reconstructive phase).
  • stress i.e., inflammatory process and aiding in the healing process.
  • This factor may need to be assessed by HgB A1C regulation as well as albumin synthesis.
  • the POP Factor weighting assignment can include: a first for a diabetic or medical stressors i.e., steroids but maintains BG equal to 60-120; a second for a BG>120 for more than 8 hours but less than 16 hours; a third for a BG>120 for more than 16 hours but less than 24 hours; and a fourth for a BG>120 for more than 24 hours.
  • H/H Low Hemoglobin/Hematocrit (H/H) represents low oxygen caring capacity leading to decreased oxygen delivery and potentially tissue oxygenation is affected. Potentially low H/H is not represented well by StO2 measurement. Massive losses quickly will affect oxygen caring capacity.
  • the POP Factor weighting assignment for Hemoglobin/Hematocrit (H/H) can include: a first for Hemoglobin 10/Hematocrit 30; a second for Hgb 9/Hct 27; a third for Hgb 8/Hct 24; and a fourth for Hgb 7/Hct 21.
  • the POP Factor weighting assignment for length of stay can include: a first where the length of stay is 1-7 days, a second where it is 8-14 days; a third where it is 15-21 days; and a fourth is greater than 21 days.
  • Previous Existing Skin Injury Previously existing wounds will only effectively heal to 80% of original strength. Thus less tolerance to new injury and stressors. Decreased tissue strength, potentially of all layers.
  • the POP Factor weighting assignment can include: a first where old pink previously healed wounds are present; a second where there are reddened areas starting around an old wound; a third where therein is difficulty with O2 and turning and known old wounds; and a fourth where wounds open again to any stage-progression will be quick.
  • Albumin holds oncotic pressure. From the dietary standpoint measurement of albumin is not a fair indicator of nutrition in a stress r/t situation due to the massive consumption and inability to use or synthesize prealbumin. However to note the concentration will quickly indicate oncotic hold. When Alb is low and fluid third spaces “water sits” between vessel and tissue. Thus, creating QS/QT at tissue level. Not allowing for distant tissue oxygenation. Also, perpetuating skin stretching effect, thinning it and increasing the stretch and strain from inside to out.
  • the POP Factor weighting assignment can include: a first where the albumin level is 3.5 to more than 3.0; a second where the albumin level is 3.0 to more than 2.5; a third where the albumin level is 2.5 to more than 2.0; and a fourth where the albumin level is less than 2.0.
  • the POP Factor weighting assignments can include a first where there is a regular redistribution bed with Braden ⁇ 14 and >12 for 12 hours; a second where there is a regular distribution bed with Braden ⁇ 12 and >10 for 12 hour shift; a third where there is a regular distribution bed with Braden ⁇ 10 and >8 for 12 hour shift; and a fourth where there is a regular distribution bed with Braden ⁇ 8 for 12 hours or greater.
  • Critically ill patients may not move in response to pain to decreased sensation of pain or weakness. Critically ill patients may be unable to redistribute weight at all due to chemically induced paralysis or a physiologic paralysis due to injury or illness, either factor impairs movement and direct interface forces may be extensive in time.
  • the POP Factor weighting assignment can include: a first where the patient moves himself or herself but must be reminded; a second where the patient must be turned with full assist q2 and requires mechanical loading; a third where the patient must be turned q2 due to immobility but is unstable and can only have 10-20 degree tilt and may not tolerate it and or may be associated with recovery and desat time; and a fourth where the patient is unable to turn due to severe pain or severity of critical illness and medical instability.
  • StO2 can provide for the measurement and/or early detection of oxygen deprivation at a tissue level. StO2 measurement can indicate O2 delivery and consumption imbalance, but does not measure O2 consumption. Measurement of StO2 can aid in the identification of early stages of tissue injury at a micro capillary level, by measuring changes as they occur. This can aid in the earlier identification of the “at risk group.” StO2 can illustrate the pathway of skin failure, time line, cause, and affects and aid in the application of appropriate equipment and measurable measures and evaluation thereof. StO2 can aid in the identification of the invisible offenders that decrease tissue oxygenation by capturing the changes at the microcirculation level of the patient.
  • the POP Factor weighting assignment for StO2 can include: a first for StO2 levels of WNL SO2 are less than 10 percent of normal; a second for StO2 is between 10 and 20 percent of normal; a third for StO2 is between 20 and 30 percent of normal; and a fourth for StO2 is greater than 30 percent of normal.
  • StO2 measurement can provide evidence based medicine (EBM) of a measured amount that will quantify as oxygen deprivation thus creating injury from inside out, e.g., deep tissue injury.
  • EBM evidence based medicine
  • the measurement of StO2 will help in conjunction with the system and method as described herein and will illustrate the pathway of skin failure, time line, cause and effect, appropriate equipment usage there will be measurable numbers to the invisible offenders that decrease tissue oxygenation.
  • Caustic events and factors that can result in pressure ulcers in patients, even where appropriate medical care is provided in a competent and timely manner, will be identifiable on a per patient basis and can aid in the development of new or modified patient care procedures.
  • an overall POP Box Score or Value is determined by summing up all of the assigned weighted assignments. For example, where all 25 factors are considered, as shown in FIG. 2 , the following care analysis can be implemented, as just one example, based assigning factors from 1 to 4 to the above 26 factors. Where the POP Box score is 0 to 25, the determined medical treatment may be that no action or treatment specific for the treatment or prevention of ulcers is required or needs to be taken.
  • a determined or selected medical treatment for the prevention and treatment of ulcer's may include providing a normal turn process for the patient based on redistributing surface practice, i.e., versacare.
  • a medical care provider may determine that there is a moderate risk of the patient developing pressure ulcers.
  • the patient's care may be adapted such that there is a low air loss overlay or surface with constant air redistribution i.e., sofcare w/pump, provided to the patient.
  • the medical care professional may determine there is a high risk for skin r/t injury.
  • the medical care provider may adjust the patient's treatment to anticipate the development of pressure ulcers and as such, the patient may be provided with a low air loss bed, a more frequent turn schedule and/or continual turn bed, possibly based on staff availability.
  • the medical care provider may determine a medical treatment for the patient may include providing the patient with a low air loss bed and with continual turning. Such determinations can also be included in medical supporting software based on predetermined criteria and ratings and aid in providing the medical care professional with recommended treatments.
  • the systems and methods described herein and claimed or claimable by this disclosure provide a medical aid to healthcare and medical practitioners.
  • Nothing in this present disclosure or claims specifically identifies the particular recommended treatments based on the POP Box scores or in anyway limits or restricts those recommended treatments.
  • the determined recommended treatments of the present systems and methods are determined using the POP Box scores from the experience of the medical care providers and by standards that can be determined overall time based on the best practices in the medical profession as determined in view of the determined POP Box scores. Such determined treatments can vary by medical care provider and are expected to change over time.
  • the POP box can improve medical diagnosis and treatment for a variety of medical conditions and needs.
  • the POP Box systems and methods as described herein can, in some embodiments, help to expose variables, events and conditions that are caustic to skin integrity that have not previously been considered as risk factors.
  • the POP Box system and methods can in other embodiments, help guide the prevention and care required with the increase in risk factors such as changes in medical treatment equipment and modification to patient turn schedules.
  • the POP Box system and method can potentially increase medical care provider patient interventions for guiding appropriate staffing needs for advanced preventative care.
  • the POP Box system and method can establish, or help the care givers establish, a fixed set of risk variables that can be utilized for risk assessment and allocation by various stakeholders, by quantifying and organizing the factors so they can be understood and tabulated.
  • the POP Box system can establish factors or help the care giver in establishing the factors, assessment and guidelines for determining the severity of particular patient status or underlying illness and conditions for inclusion in assessing medical treatments and life lengthening decisions.
  • an operating environment for an exemplary embodiment of a Pressure, Oxygenation, and Perfusion (POP) Box system and method including one or more components or modules thereof is a computer system 300 with a computer 302 that comprises at least one high speed processing System (CPU) 304 , in conjunction with a memory system 306 interconnected with at least one bus structure 308 , an input device 310 , and an output device 312 . These elements are interconnected by at least one bus structure 312 .
  • CPU high speed processing System
  • the illustrated CPU 304 is of familiar design and includes an arithmetic logic unit (ALU) 314 for performing computations, a collection of registers 314 for temporary storage of data and instructions, and a control System 316 for controlling operation of the system 300 .
  • ALU arithmetic logic unit
  • the illustrated embodiment of the system operates on an operating system designed to be portable to any of these processing platforms.
  • the memory system 306 generally includes high-speed main memory 320 in the form of a medium such as random access memory (RAM) and read only memory (ROM) semiconductor devices, and secondary storage 322 in the form of long term storage mediums such as floppy disks, hard disks, tape, CD-ROM, flash memory, etc. and other devices that store data using electrical, magnetic, optical or other recording media.
  • the main memory 320 also can include video display memory for displaying images through a display device.
  • the memory system 306 can comprise a variety of alternative components having a variety of storage capacities and can include a subscriber identity or information module (SIM) such as a GSM SIM Card, in one embodiment.
  • SIM subscriber identity or information module
  • the input device 310 and output device 312 are also familiar.
  • the input device 310 typically comprises a keyboard, but can also include a mouse, a touch screen, a physical transducer (e.g. a microphone), etc. and is interconnected to the computer 302 via an input interface 324 .
  • the output device 312 can comprise a display but can also include a printer, a transducer (e.g. a speaker), etc, and be interconnected to the computer 302 via an output interface 326 .
  • Some devices, such as a network adapter or a modem, can be used as input and/or output devices.
  • the computer system 300 further includes an operating system and at least one application program.
  • the operating system is the set of software which controls the computer system's operation and the allocation of resources.
  • the application program is the set of software that performs a task desired by the user, using computer resources made available through the operating system. Both are resident in the illustrated memory system 306 .
  • the present system is described below with reference to symbolic representations of operations that are performed by the computer system 300 . Such operations are sometimes referred to as being computer-executed. It will be appreciated that the operations which are symbolically represented include the manipulation by the CPU 304 of electrical signals representing data bits and the maintenance of data bits at memory locations in the memory system 306 , as well as other processing of signals.
  • the memory locations where data bits are maintained are physical locations that have particular electrical, magnetic, or optical properties corresponding to the data bits.
  • the system can be implemented in a program or programs, comprising a series of instructions stored on a computer-readable medium.
  • the computer-readable medium can be any of the devices, or a combination of the devices, described above in connection with the memory system 306 .
  • the method starts 402 with a measurement of a patient's skin pressure 404 .
  • the measured skin pressure is input at 406 into a computer system such as system 300 via an input device 310 and stored in memory 306 .
  • the system 300 includes computer implementable instructions for assigning a rating in 408 to skin pressure based on predetermined allocations such as those described above by way of example.
  • the assigned skin pressure rating of 408 is also stored in memory 306 .
  • the tissue oxygenation of the patient is measured in 410 and entered and received by system 300 in 412 .
  • the system assigned a tissue oxygenation rating in 414 and both the measured tissue oxygenation and the assign tissue oxygenation rating are stored in memory 306 .
  • the perfusion is measured in 416 and received by the system 300 in 418 .
  • the system 300 assigns a perfusion rating in 420 . Both the measured perfusion and the assigned perfusion rating are stored in memory 306 .
  • these three variables of skin pressure, tissue oxygenation, and perfusion are exemplary variables or factors. Additional or different variables and factors can be implemented by some embodiments of the method and still be within the scope of the present disclosure.
  • the system 300 sums the available factor ratings in 422 to determine a POP Box Score.
  • summing is identified as one method or algorithm for determining the POP Box Score, those skilled in the art will understand that other methods and algorithms can be utilized to determine the POP Box Score of the various selected and/or included factors and still be within the scope of the present disclosure.
  • the total POP Box Score is provided to a comparison process of 424 for comparison to determine the risks to the patient for pressure related skin injury and determining a recommended treatment.
  • a plurality of risks for pressure related skin injury and recommended treatments are predetermined and scored by medical professionals and stored in memory 306 . Each of these risks and recommended treatments can include one or more assigned POP Box Score.
  • the patient's POP Box score of process 422 is compared in process 424 with the predetermined or allocated ratings obtained from process 426 in process 428 and a recommended treatment is determined in 430 based on the comparison process 424 and the determined risk of 428 .
  • the determined recommended treatment of 430 can be presented to the medical care provider as an output of the system 300 such as inclusion in a report or as a presentation at the output interface 312 .
  • the medical care provider can be presented with the determined risk 428 and recommended treatment 430 and can also be presented with some or all of the stored measurements and assigned ratings for final selection by the medical care provider of the treatment of the patient.
  • the determined recommended treatment is also stored in memory 306 .

Abstract

A system or method for assessing a patient for pressure related skin injury risk and recommended treatment including measuring extrinsic and intrinsic skin pressure of the patient and assigning a rating responsive to the skin pressure measurement, measuring oxygenation of the patient and assigning a rating responsive to the oxygenation measurement, measuring perfusion of the patient and assigning a rating responsive to the perfusion measurement, summing the skin pressure, oxygenation and perfusion ratings to obtain a POP Box score, determining a risk of pressure related skin injury for the patient in response to the POP Box score, and determining or selecting a recommended treatment from among a plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application claims the benefit of U.S. Provisional Application No. 61/183,667, filed on Jun. 3, 2009, the disclosure of which is incorporated herein by reference.
  • FIELD
  • The present disclosure relates to methods and systems for medical evaluation care and, more specifically, to systems and methods for evaluating a patient for pressure related skin injury risk and recommended treatment.
  • BACKGROUND
  • The statements in this section merely provide background information related to the present disclosure and may not constitute prior art.
  • In medical treatment, pressure ulcers are currently tagged as hospital acquired conditions (HAC) unless they were present on admission (POA) of the patient. When pressure ulcers are classified as HAC, they are almost always considered to be preventable with appropriate treatment. It has been estimated that the cost in the United States for treating stage 3-4 pressure ulcers can be as high as $11 Billion annually. However, the costs for treatment of such patient conditions are withheld per guidelines for pressure ulcers as issued by the Center for Medicare and Medicaid Services (CMS).
  • The current risk identification tools used most commonly for assessment of patient risk of pressure related skin injury are the Braden (copy attached as FIG. 1 by way of example) and the Norton scale (not attached). These tools have become the gold standard for basic risk assessment. However, as described herein, these tools are only the start of the necessary assessment for risk related injury as neither scale addresses the more complex components of critical illness, physiological responses and treatments. All of which have non-visible caustic potential.
  • While measures should be taken to prevent pressure related injury during medical treatment or a hospital stay, pressure ulcers have been found to occur regardless of strict compliance to preventative measures such as the regular turning of bed ridden patients every two hours, (i.e., turn q2), the redistribution of a patient's weight, mechanical loading and nutritional support. Patients continue to suffer from skin injury even where medical and nursing care is diligent and timely consistent with best practices.
  • SUMMARY
  • As addressed herein, the inventor hereof has determined that not all pressure sores or pressure ulcers, even though not initially POA, are purely due to poor nursing care or improper application of medical treatment and found that there are other characteristics and factors that need to be considered when evaluating a patient and providing treatment to a patient. As described herein are new and improved systems and methods for evaluating risk of patients for pressure related injury. These systems and methods can, in some embodiments, provide a more extensive system than currently used and that is inclusive of interrelated variables that can effect integrity of skin or rather the impairment of skin integrity. These variables or factors may be either extrinsic or intrinsic in nature.
  • As described herein, the Pressure, Oxygenation, and Perfusion (POP) Box (hereinafter “POP Box”) systems and methods have been created to expose and apply physiologic factors that lead to skin failure and increased risk of pressure ulcers. In general these intrinsic and/or extrinsic variables and factors have been determined by the inventor to affect pressure, oxygenation or perfusion to skin surface. The POP Box as described herein builds on prior assessments and applies a variety of factors related to the integumentary system, homeostasis and physiological stressors that more fully addresses risks for each patient. The present method and system does not stop or limit itself to the prior risk factors teachings and belief that following the current care practices will prevent pressure ulcers in all cases. The use of the POP Box as described herein utilization, will not by itself prevent all HAC pressure ulcers even with excellent health care, as the inventor hereof has determined that not all HAC pressure ulcers are preventable. For example, it has been determined that some pressure ulcers are the result not of poor nursing care, but are associated with impaired tissue oxygenation that can occur as a result of a large number of factors, other than medical care practitioners following pre-established bedside procedures.
  • The systems and procedures as described herein are consistent with other evidence based medicine (EBM) procedures for enhancement of health care services. The inventor has determined that it is highly likely that the affects of pressure, oxygenation and perfusion at a microvascular level provide additional variables that can often lead to skin injury. As described herein, underlying health conditions and insults at a micro vascular level can cause and/or hasten skin failure, such as with pressure ulcers. The complex medical conditions that are aggressively and successfully treated may ultimately leave the integumentary system strained. Potential is high for skin insults and/or injuries related to intrinsic responses to constitutional stressors and its treatment. The human body's adaptive responses while seeking homeostasis in stressful situations are often caustic to the skin.
  • The POP box has been created to expose other insults to patients that can lead to skin failure. In particular, it has been created to identify the extrinsic and intrinsic patient factors leading to skin breakdown and to remove the fault of the nurse in skin injury.
  • The POP Box system and method as described herein utilize the identified variables that have been determined to affect tissue oxygenation. However, it also recognizes that the measurement of local tissue oxygen saturation (StO2), which can be measured in the tissue microcirculation, will become more common place in the health care environment and as such, the systems and methods described herein will improve the assessment of the risks and prediction of pressure related injury over prior systems and methods. This includes the determination of pressure related injury that occurs from inside the body such as from deep tissue injury, rather than externally applied as previously believed in many cases. As described herein the POP Box can also be named, for example as the “Oxy Bin” illustrating the “bin” or “box” nature of considering the various oxygenation variables in an assessment system and method.
  • According to one aspect, a system for assessing a patient for pressure related skin injury risk and recommended treatment includes a memory, an input device, an output device, and a processor. The memory and processor include computer executable instructions for implementing the method of receiving a measured pressure on the skin of the patient, and assigning a rating responsive to the received pressure measurement. The method also includes receiving a measured tissue oxygenation of the patient and assigning a rating responsive to the received oxygenation measurement. The method further includes receiving a measured perfusion of the patient and assigning a rating responsive to the received perfusion measurement. The method also includes summing the pressure, tissue oxygenation and perfusion ratings to obtain a POP Box score, determining a risk of pressure related skin injury for the patient in response to the POP Box score and determining a recommended treatment from among a plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury.
  • In another aspect, computer readable medium having computer executable instructions for assessing a patient for pressure related skin injury risk and recommended treatment include computer executable instructions performing the method of receiving a measured skin pressure of the patient and assigning a rating responsive to the received skin pressure measurement. The method also includes receiving a measured oxygenation of the patient and assigning a rating responsive to the received oxygenation measurement. The method further includes receiving a measured perfusion of the patient and assigning a rating responsive to the received perfusion measurement. The method also includes summing the skin pressure, oxygenation and perfusion ratings to obtain a POP Box score, determining a risk of pressure related skin injury for the patient in response to the POP Box score. and determining a recommended treatment from among a plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury.
  • In yet another aspect, a method for assessing a patient for pressure related skin injury risk and recommended treatment includes measuring skin pressure of the patient and assigning a rating responsive to the skin pressure measurement, measuring tissue oxygenation of the patient and assigning a rating responsive to the tissue oxygenation measurement, and measuring perfusion of the patient and assigning a rating responsive to the perfusion measurement. The method also includes summing the skin pressure, tissue oxygenation and perfusion ratings to obtain a POP Box score, determining a risk of pressure related skin injury for the patient in response to the POP Box score, and determining a recommended treatment from among a plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury.
  • According to another aspect, such methods can include measuring skin pressure of the patient and assigning a rating responsive to the skin pressure measurement, measuring oxygenation of the patient and assigning a rating responsive to the oxygenation measurement, measuring perfusion of the patient and assigning a rating responsive to the perfusion measurement, summing the skin pressure, oxygenation and perfusion ratings to obtain a POP Box score, determining a risk of pressure related skin injury for the patient in response to the POP Box score, and determining a recommended treatment from among a plurality of available recommended treatments for the patient in response to the determined risk of pressure related skin injury.
  • In accordance with another aspect, a system or method for assessing a patient for pressure related skin injury risk and recommended treatment including measuring StO2 in the patient and assigning a first StO2 rating where StO2 levels of WNL SO2 are less than 10 percent of normal; assigning a second StO2 rating where StO2 is between 10 and 20 percent of normal; assigning a third StO2 rating where StO2 is between 20 and 30 percent of normal; and assigning a fourth StO2 rating where StO2 is greater than 30 percent of normal.
  • The method also includes summing the assigned ratings to obtain a POP Box score, and determining a risk of pressure related skin injury for the patient in response to the POP Box score, and determining or selecting a recommended treatment from among a plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury.
  • In yet another aspect, a system or method for assessing a patient for pressure related skin injury risk and recommended treatment including evaluating the patient based on a review of various factors and assigning a rating responsive to the evaluations including measuring StO2 in the patient and assigning a rating responsive to the StO2 measurement. The method can also include one or more of the following additional processes: determining an age of the patient and assigning a rating responsive to the determining; determining a body mass index of the patient and assigning a rating responsive to the determining; determining whether the patient was found in a down position prior to evaluation and assigning a rating responsive to the determining; determining an operating room variable of the patient wherein in the assigning is responsive to the number of such operating room variables present; determining a presence of one or more disease processes present in the patient wherein in the assigning is responsive to the number of such disease processes are present; determining steroid use by the patient and assigning a rating responsive to the determining; determining LOS for both ICU and regular hospital stays for the patient and assigning a rating responsive to the determining; determining a pressure redistribution surface time of the patient and assigning a rating responsive to the determining; determining a presence of pain or paralysis of the patient and assigning a rating responsive to the determining; measuring a vital sign of the patient including the blood pressure and heart rate and assigning a rating responsive to the measuring; measuring a venous oxygen saturation (SvO2) or central venous oxygen saturation (SvcO2) and assigning a rating responsive to the measuring; measuring a ratio of arterial oxygen concentration to the fraction of inspired oxygen (referred commonly as the P/F ratio) of the patient and assigning a rating responsive to the measuring; measuring a desaturation recovery time oxygen saturation (SpO2) or oxygen attached to the haemoglobin cell in the circulatory system of a patient and assigning a rating responsive to the measuring; measuring a cardiac index (CI), cardiac output (CO) and/or Stroke Volume (SV) of the patient and assigning a rating responsive to the measuring; measuring an Edema of the patient and assigning a rating responsive to the measuring; measuring a blood glucose of a patient and assigning a rating responsive to the measuring; measuring a hemogolin/hematocrit (H/H) of the patient and assigning a rating responsive to the measuring; measuring a Albumin level of the patient and assigning a rating responsive to the measuring; identifying a presence of one or more pressor agents and assigning a rating responsive to the identifying; evaluating an emergency room procedure experience by the patient and assigning a rating responsive to the evaluating; identifying a presence of one or more mechanical apparatus associated with the patient wherein in the assigning is responsive to the number of identified apparatus present; identifying maceration can include identifying moisture content of linens and clothing of the patient and assigning a rating responsive to the identifying; and identifying previous or existing skin injury of the patient and assigning a rating responsive to the identifying; summing the assigned ratings from the Braden Score and the StO2 measurement to obtain a POP Box score, determining a risk of pressure related skin injury for the patient in response to the POP Box score, wherein the ratings for each factor is from 1 to 4, and wherein determining a recommended treatment for the patient in response to the determined risk of pressure related skin injury wherein the POP Box score is 0 to 25, take no action; wherein the POP Box score is 25 to 50, provide normal turn on redistributing surface practice; wherein the POP Box score is 50 to 75, adapt patient care for low air loss overlay or surface with constant air redistribution; wherein the POP Box score is between 75 and 100, provide patient with a low air loss bed, provide a more frequent turn schedule and/or continual turn bed; and wherein the POP Box score is greater than 100, provide patient with a low air loss bed with continual turning.
  • Further aspects of the present disclosure will be in part apparent and in part pointed out below. It should be understood that various aspects of the disclosure may be implemented individually or in combination with one another. It should also be understood that the detailed description and drawings, while indicating certain exemplary embodiments, are intended for purposes of illustration only and should not be construed as limiting the scope of the disclosure.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a chart of a Braden Scale for Predicting Pressure Sore Risk as currently used in the art.
  • FIG. 2 is a chart of the Pressure, Oxygenation, and Perfusion (POP) Box system and method according to one exemplary embodiment of the disclosure.
  • FIG. 3 is a block diagram of a computer system that may be used to implement one or more exemplary embodiments and/or one or more components or modules of the Pressure, Oxygenation, and Perfusion (POP) Box system and method as described herein.
  • FIG. 4 is a flow chart diagram of a method for assessing a patient for pressure related skin injury risk and recommended treatment according to one exemplary embodiment.
  • It should be understood that throughout the drawings, corresponding reference numerals indicate like or corresponding parts and features.
  • DETAILED DESCRIPTION
  • The following description is merely exemplary in nature and is not intended to limit the present disclosure or the disclosure's applications or uses.
  • Before turning to the figures and the various exemplary embodiments illustrated therein, a detailed overview of various embodiments and aspects is provided for purposes of breadth of scope, context, clarity, and completeness.
  • According to one embodiment, a system or method for assessing a patient for pressure related skin injury risk and recommended treatment including measuring skin pressure of the patient and assigning a rating responsive to the skin pressure measurement, measuring oxygenation of the patient and assigning a rating responsive to the oxygenation measurement, measuring perfusion of the patient and assigning a rating responsive to the perfusion measurement, summing the pressure, oxygenation and perfusion ratings to obtain a POP Box score, determining a risk of pressure related skin injury for the patient in response to the POP Box score, and selecting or determining a recommended treatment for the patient in response to the determined risk of pressure related skin injury. As discussed herein, skin pressure or sometimes just pressure refer to intrinsic and extrinsic forces that are applied to the skin that can result in injury to the skin resulting from such forces.
  • As noted above, while the process herein includes selecting and/or determining a recommended treatment, nothing in this present disclosure or claims specifically identifies the particular treatments based on the POP Box scores or in anyway limits or restricts those treatments. The determined recommended treatments of the present systems and methods are determined using the POP Box scores from the experience of the medical care providers and by standards that can be determined overall time based on the best practices in the medical profession as determined in view of the determined POP Box scores. Such determined recommended treatments can vary by medical care provider and are expected to change over time.
  • A risk of pressure related skin injury is determined for the patient in response to the POP Box score. A recommended treatment for the patient is then selected in response to the determined risk of pressure related skin injury. This later can include, but is not limited to, assigning ratings on a scale of 1 to 4 and taking no action with the POP Box score is 0 to 25, but where the POP Box score is 25 to 50, provide normal turn on redistributing surface practice, the POP Box score is 50 to 75, adapt patient care for low air loss overlay or surface with constant air redistribution, the POP Box score is between 75 and 100, provide patient with a low air loss bed, provide a more frequent turn schedule and/or continual turn bed; and where the POP Box score is greater than 100, provide patient with a low air loss bed with continual turning.
  • Of course, one skilled in the art will understand that additional factors can also be considered and still be within the scope of the present disclosure. These can include one or more of the following factors, alone or in additional combinations. It should also be understood that the rating of 1 to 4 for each is only one exemplary embodiment. Each factor can have more or less ratings and each may have a different rating range or weighting and still be within the scope of the present disclosure.
  • The method can include evaluating the patient using Braden Scale to obtain a Braden Score and assigning a rating from 1 to 4 responsive to the Braden Score. the Braden Score can be included in the POP Box score for evaluation and selection of the treatment for the patient.
  • Of course, additional factors in addition to the Braden scale score and the measurement of tissue oxygenation such as by measurement of local tissue oxygen saturation (StO2) by measurement of the microcirculation in the tissue using an StO2 monitoring device), can be utilized according to the present methods and systems. StO2 as a measurement of tissue oxygenation can be measured in the microcirculation where oxygen is exchanged with tissue such as by continuous measurement/monitoring of peripheral perfusion, as known to those of skill in the art.
  • As one example of the StO2 rating, the method provides for assigning a first StO2 rating where StO2 levels of WNL SO2 are less than 10 percent of normal; assigning a second StO2 rating where StO2 is between 10 and 20 percent of normal; assigning a third StO2 rating where StO2 is between 20 and 30 percent of normal; and assigning a fourth StO2 rating where StO2 is greater than 30 percent of normal. As StO2 monitoring becomes more widely available to medical personnel that may be due in part to its significant benefit in analyzing pressure ulcer risks, the variables as identified herein and their various determined numerical value assignments can provide medical care personnel with a significant improvement in medical diagnosis and improved patient care.
  • The method can include one or more of the following processes that can be included as factors in predicting pressure sore risk and in determining appropriate recommended treatments. These can include one or more of:
  • a. determining whether the patient was found in a down position prior to evaluation and assigning a rating responsive to the determining;
  • b. determining an operating room variable of the patient wherein in the assigning is responsive to the number of such operating room variables present; determining a presence of one or more disease processes present in the patient wherein in the assigning is responsive to the number of such disease processes are present;
  • c. determining steroid use by the patient and assigning a rating responsive to the determining;
  • d. determining LOS for both ICU and regular hospital stays for the patient and assigning a rating responsive to the determining;
  • e. determining a pressure redistribution surface time of the patient and assigning a rating responsive to the determining; determining a presence of pain or paralysis of the patient and assigning a rating responsive to the determining;
  • f. measuring a vital sign of the patient including the blood pressure and heart rate and assigning a rating responsive to the measuring (such as heart rate (HR); Systolic blood pressure (SBP); diastolic blood pressure (DBP); and mean arterial pressure (MAP));
  • g. measuring a venous oxygen saturation (SvO2) or central venous oxygen saturation (SvcO2) and assigning a rating responsive to the measuring;
  • h. measuring a P/F ratio (the ratio of arterial oxygen concentration to the fraction of inspired oxygen) of the patient and assigning a rating responsive to the measuring;
  • i. measuring a desaturation recovery time of an oxygen saturation (SpO2) of the patient and assigning a rating responsive to the measuring;
  • j. measuring a Cardiac Index (CI) or Cardiac Output (CO) of the patient and assigning a rating responsive to the measuring;
  • k. measuring an Edema of the patient and assigning a rating responsive to the measuring;
  • l. measuring a blood glucose of a patient and assigning a rating responsive to the measuring; measuring a hemogolin/hematocrit (H/H) of the patient and assigning a rating responsive to the measuring;
  • m. measuring a Albumin level of the patient and assigning a rating responsive to the measuring;
  • n. identifying a presence of one or more pressor agents and assigning a rating responsive to the identifying;
  • o. evaluating an emergency room procedure experience by the patient and assigning a rating responsive to the evaluating;
  • p. identifying a presence of one or more mechanical apparatus associated with the patient wherein in the assigning is responsive to the number of identified apparatus present;
  • q. identifying maceration, that can include identifying moisture content of linens and clothing of the patient, for example, and assigning a rating responsive to the identifying; and
  • r. identifying previous or existing skin injury of the patient and assigning a rating responsive to the identifying;
  • It would be understood to those of skill in the art that these factors are only representative factors and that other factors may also be identified and rated and included in the overall POP Box score for use in determining treatment plans for patients. While not listed for instance, the gender and race of the patient may be additional factors in some embodiments. As noted, not all of the factors are necessarily and a subset of the factors are possible and expected in some embodiments. Additionally, as StO2 is a relatively new measureable characteristic that has been identified as one POP Box factor, other new patient measurements and characteristics are also possible in the future as technology and medical understanding for diagnosis develops. These new diagnosis variables can be included in other embodiments and are considered to be within the scope of the present disclosure.
  • 1. Patient Diagnosis
  • In some embodiments, the Pressure, Oxygenation, and Perfusion (POP) Box (POP Box) system and method can include all or a portion of the following evaluation factors and POP Factor Assessment Value (POP FAV) (in this example of assigning a rating from 1 to 4 for each factor). It should be understood to those skilled in the art that one or several of these factors may not be applicable to a particular patient and therefore not applicable to the current system and method, generally on a patient by patient basis.
  • 2. Exemplary POP Box Factors and Weightings
  • The following exemplary POP Box Factor analysis addresses 25 exemplary intrinsic and extrinsic factors, some or all of them can be included in the POP Box as may be determined suitable for particular uses and as determined overtime by a medical care practitioner. This example allocates each of these into four categories for ratings and assignment of ratings. Of course one skilled in the art will understand that a more or less granular rating assignment scheme can also be employed and still be within the scope of the present disclosure and claims.
  • A. Braden Scale: As the prior art use of the Braden Scale For Predicting Pressure Sore Risk can decrease the risk for associated pressure injury increases. In one embodiment, a POP Factor weighting assignment includes as one factor a Braden Scale assessment having different POP Box categories allocations for factor weighting: a first for a Braden score of 17-15; a second for a Braden score of 14-12; a third for a Braden score of 12-10; and a fourth for a Braden score of 9 and below. As noted in FIG. 1, the Braden scale of FIG. 1 is a copyrighted document of Barbara Braden and Nancy Bergstrom, 1988.
  • B. Patient Age: As a person ages the subcutaneous layer is decreased due to less collagen production. The collagen composition is affected due to a decrease in intrinsic hormone mediators (usually estrogen), that therefore decreases the production of collagen. With less collagen in the subcutaneous tissue, there is a decrease in surface area protection and elasticity. Regarding vasculature, though collateral circulation is more defined in the older person the possibility for oxygenation to be compromised is increased as well. With the increase of age exposure to CAD pressure ulcer risk causing factors are also increased. The POP Factor B Weighting Assignment of the patient's age into the four exemplary categories can include the following, one category classification for each of: a first for an age range of 20-40 years old; a second for an age range of age 40-60 years old; a third for an age range of age 60-80 years old; and a fourth for an age of older than 80.
  • C. Body Mass Index (BMI): The following factors are considered as increased risk factors associated with an increased BMI: HTN, Dyslipidemia, DM2, CAD, and Sleep Apnea, according to some embodiments. All of these conditions can be associated with perfusion or oxygenation compromise. Increasing risk for damage from oxygen deprivation at the peripheral vascular level. A different POP Factor for a weighting assignment of the BMI can include: a first for a normal weight but Body Mass Index compromised below 2; a second for an underweight where the weight is more than 18.5 under normal; a third for an overweight condition such as when the weight is between 25-29.9 above normal; and a fourth for an obese weight of a BMI of 30 or greater.
  • D. Found Down: When a patient has been found down, deep tissue injury is suspected to happen from interface forces. The longer the contact time of immobility on a hard surface the greater the increased risk of decreased tissue perfusion and oxygenation thus increasing risk of deep tissue injury. This injury takes hours to days to appear. Therefore, the fact that a patient is found down after a fall has not been previously considered a risk factor, however, this is included here as having been determined to be another POP Box factor. The POP Factor for weighting assignment for the factor of the patient being found in a down position can include: a first when found down for short period of time less than 1 hour; a second when found down between 1 to 2 hours wherein the ph and lactate may/or may not be affected; a third when found down between 2 to 5 hours and wherein a ph measurement is down and lactate is identified as being elevated; and a fourth when found down greater than 5 hours and where the measured ph is down and lactate is up, with potentially MB-CPK (creatine phosphokinase-MB (CPK-MB)) is up. The CPK-MB measurement is a cardiac marker often used to assist diagnoses of an acute myocardial infarction.
  • E. Vital Signs: Vital signs can include the patient's heart rate (HR); Systolic blood pressure (SBP); diastolic blood pressure (DBP); and/or mean arterial pressure (MAP). This can also include instability such as Tachycardia and Hypotension. With decrease in blood pressure (B/P), it would be assumed that tissue perfusion and ultimately tissue oxygenation are effected. When increased HR atrial kick is lost, cardiac output is decreased and potential for a decrease in perfusion state exists. There is a potential for 20% of blood volume (stroke volume) to be lost. Increased skin temperature can improve perfusion but increases in temperature increases oxygen consumption. Furthermore a febrile state may increase vasodilatation and skins perfusion but rigors in this febrile state will increase oxygen consumption (VO). Conversely, hypothermia would simply represent decreased perfusion due to vasoconstriction and decreased tissue perfusion. The POP Factor weighting assignment for measured vital signs can include an allocation to four categories, for example: a first for HR within normal levels (WNL), SBP<90 DBP<60, MAP<60; a second for HR>100, SBP<85 DBP<50, MAP<55; a third for HR>120, SBP<70 DBP<45, MAP<50; and a fourth for HR in/out>140, SBP 70 or less with tacky: DBP and MAP critically low. These of course can change and the categorization made more complex with various combinations of measurements.
  • F. Pressor Agents: With the use of vaso active agents to enhance cardiac output and brain and heart perfusion, it is known that the periphery is vasoconstricted to increase cardiac return, thus, blood volume is taken from the periphery to the core. This factor addresses the caustic affects to the integument system by those known vasoconstriction agents. The POP Factor weighting assignment for identified or measured pressor agents can include: a first for Dopamine at 5 mcg/kg/min or Levophed 5-10 mcg/min; a second for Dopamine 10-15 mcg/kg/min or Levophed 10-15 mcg/min; a third for Dopamine 15-25 mcg/kg/min or Levophed 15-25 mcg/min; and a fourth for Dopamine ineffective or Levophed>25 mcg/min.
  • G. SvO2 or ScvO2: A venous oxygen saturation (SvO2) or central venous oxygen saturation (ScvO2) represents the venous return side. Correlation of tissue oxygenation and extraction are interrelated. Poor (low or very high SvO2) can represent limited oxygen extraction. It may also represent limited oxygen carrying capacity. At this time, SvO2 is the closest number for tissue oxygenation/extraction known. Different shock states will have variable SvO2 values but are expected to have the same effect to the skin. While measurement of the change in the SvO2 is often not available due to its invasiveness, when available to be measured, it can contribute useful information regarding systemic oxygenation delivery and consumption. The POP Factor weighting a for assignments for measured venous oxygen saturation (SvO2) or central venous oxygen saturation (ScvO2) can include: a first for a measured SvO2<60 or >75; a second for a measured SvO2 of 40-50 cardiogenic/75-80 septic shock; a third for a measured SvO2<40 cardiogenic/80-90 septic shock; and a fourth for a measured SvO2<30 cardogenic shock/>90 septic shock.
  • H. P/F Ratio: The ratio of arterial oxygen concentration to the fraction of inspired oxygen (P/F ratio) can also be a factor as a decreasing P/F ratio, e.g., PaO2/FiO, may indicate the capability to upload oxygen to hemoglobin is affected. Therefore, P/F ratio measurement can assist with assessment of factors affecting oxygenation at all levels. The POP Factor weighting assignment for the P/F Ratio can include: a first for a P/F ratio 280-250; a second for a P/F ratio 250-200; a third for a P/F ratio 200-150; and a fourth for a P/F ratio of less than 150.
  • I. Desaturation Recovery Time (Oxygen Saturation SpO2=90 or >): When turning and moving the critically ill patient there will be periods of desaturation with various recovery time with position changes and other procedures. This comes from the movement of blood in areas of shunts and changes in DO2 and VO2. Patients left sedentary are potentially more affected. However an increase in recovery time would represent the decrease in tissue perfusion. Separate consideration can be provided when SpO2 is less than 90, for example. The POP Factor weighting assignment for SpO2 can include: a first for a recovery time of 1-2 minutes; a second for a recovery time of 2-5 minutes; a third for a recovery time of 5-10 minutes; and a fourth for a recovery time of greater than 10 minutes
  • J. CO/CI/SV: With the decrease in cardiac function tissue, perfusion is affected, thus tissue oxygenation. Evaluation of the cardiac output, the cardiac index and/or the stroke volume (SV) can be indicative and instructive. Poor EF and Poor SV will result in a decrease in distal tissue perfusion. As CI goes down, the Stroke Volume (SV) will increase thus potentiating decreased tissue oxygenation at peripheral locations. The POP Factor weighting assignment for Cardiac Output (CO) and/or Cardiac Index (CI) can include: a first for CI-2.5 BNP>100 or SV>60; a second for CI<2.0 BNP>200 or 60<SV>55; a third for CI<1.5 BNP>500 or 55<SV>50; and a fourth for CI<1.0 BNP>800 or SV<50.
  • K. Massive Edema: The massive edema can include—Sepsis fluid resuscitation, acute renal failure (ARF), and low albumin. During critical illness, the body's homeostatic mechanisms lead to fluid retention. The body can swell more that 4+ anascarca by retaining extra fluids. In fact, the body can hold liters of extra fluid and stretch the integumentary system that can result in cracking and blistering of the skin. At such points of failure, weeping will start and constant moisture expulsion will ensue. Additionally, maceration and deterioration to the skin will happen. When both albumin and oncotic pressure are low, fluid shifts to a third space. This can create a possible shunt between oxygen and the skin and can also increase the surface area required for perfusion in an already compromised perfusion state. The POP Factor weighting assignment for edema can include: a first for Edema considered to be +1 mm with finger compression; a second for Edema considered to be +2 mm with finger compression; a first for Edema considered to be +3 mm with finger compression; and a fourth for Edema considered to be +4 or greater with finger compression.
  • L. Operating Room Procedure: With any invasive procedure there are variables that effect tissue oxygenation and perfusion. Skin would be more vulnerable to stress related injury. During surgery, a prolonged period of immobility exists similar to the “found down” factor yet in a monitored environment. However, variable conditions occur in the operating room (OR) contributing to an increased risk of skin breakdown. These can include one or more of the following: a. time on OR table>4 hours-especially w/o pressure reducing device; b. Chilling of core temp—decrease bleeding; c. Not placed on pressure reducing surface while reperfusion; d. Drop of MAP<55; e. Use of Neo stick or presser agent to recover B/P; f. Use of Heart-Lung bypass machine; g. PAR instability; and/or h. excessive bleeding (can be defined by way of example as bleeding greater than 6 U of PRBC's required in a 24 hour perioperative period). The POP Factor weighting assignment for the operating room procedures can include: a first where 1-2 variables are present or identified; a second wherein 3-4 variables are present; a third where 5-6 variables are present; and a fourth where there are 7 or more variables present.
  • M. Emergency Room (ER) Time: A patient can have an extensive stay while awaiting treatment and a room. Often there is no pressure redistributing device either for chairs or stretchers. Additionally, trauma patients are on a hard backboard. As a result, the amount of time until treatment needs to be considered. The POP Factor weighting assignment for ER time can include: a first for an ER time of 4-6 hours or less; a second for an ER time of 6-10 hours; a third for an ER time of between 11-20 hours; and a fourth for an ER time greater than 20 hours.
  • N. Apparatus With added apparatus of hard surfaces applied to the body there is likelihood of interface surface pressure. This would cause decreased perfusion, decreased oxygenation and true pressure to a surface. Furthermore, when mechanically loading it is more challenging to redistribute pressures with added weight and bulk. The apparatus factors can include the presence of each of the following as being one apparatus variable: Splint, traction, cervical collar, RPM machine, pins/rods, balloon pump, VAD, external pacemaker, and cast. For example, 2 casts+one external pacemaker=3 variables. The POP Factor weighting assignment for patient apparatus can include: a first for one apparatus variable being present; a second where there are 2 apparatus variables present; a third where there are 3 apparatus variables present; and a fourth where there are 4 or more variables present.
  • O. Disease Process: The reality of underlying disease process effecting perfusion and oxygenation is not accounted for with current risk assessment tools. With the advent of deep tissue injury (NPUAP) the understanding that injury can occur from the inside out is now understood. It has been determined that there are diseases that predispose skin to injury more quickly. Those that involve decrease perfusion and oxygenation at the tissue level are considered as such, but also can include those that involve decreased sensory and movement capability including those having a neurological effect. The possible disease process factors or variables can include: a. CAD: decreased perfusion systemically and peripherally; b. DM: vascular changes; c. CHF, CM: Decreased perfusion, vascular stress; d. COPD: Smoker-vascular, oxygenation and ventilation effect; e. Pulm HTN: decreased oxygenation, possible right to left heart shunt-decreased SaO2, potentially all pulmonary diseases to be added: IPF, CF, by ways of example. All that affects oxygenation (decreased P/F ratios); f. Vascular dx: PVD; g. Autoimmune: Vascular collagen changes at a micro vascular level; h. CF: decreased oxygenation at pulmonary level e.g., a decreased SaO2; i. Physical components: micro emboli, nail clubbing; j. PE: oxygenation effect-P/F ratio overlap; k. Renal Failure: low epogen, low O2 carrying capacity, and/or sudden changes to periphery such as changes in MAP with hemodyalysis or CVVHD; 1. ESLD: decreased albumin production, decreased oncotic pressures, decreased gluconeogenisis, decreased collagen production. Increased ascites accumulation and fluid shifts. Pleural effusion that can affect oxygenation. Edema effecting stress and tension on skin. A patient with lower B/P in general therefore with decreased MAP effecting decreased perfusion. The POP Factor weighting assignment can include: a first where one variable are present; a second where 2 variables are present; a third where 3 variables are present; and a fourth where 4 or more variables are present.
  • P. Steroids: With vascular compromise the body mounts an inflammatory response to help bring added nutrition and vascular elements to the affected area. With chronic immunosuppression, the body is unable to mount the natural inflammatory response for wound healing. With chronic steroid use there is also a decrease of Estrogen production that causes a decrease in collagen production and its protective layer at the subcutaneous layer. The POP Factor weighting assignment to consider the patient's use of steroids can include: a first category for one time yearly use for control of a disease process; a second for two times yearly with disease flare; a third for daily use with disease control; and a fourth where daily use with disease process not controlled.
  • Q. Maceration: As skin becomes macerated the integrity of the skin is threatened. Separation of epidermis from dermis in these moisture states increases the potential for skin breakdown. This is not only through incontinence and perspiration but also physiological responses such as to deprave. The POP Factor weighting assignment for identification of maceration can include: a first where linens or clothing moisture are saturated q8 hours; a second for linen change required q4 hours; a third for linens changed q2 to maintain skin dryness; and a fourth where it is not possible to fully stop constant moisture i.e., greater that +4 edema that has stretched and is now constantly leaking fluids due to impaired integumentary
  • R. Blood Glucose: Cellular activity is most functional when availability of Insulin for cellular activity (enzymatic transport) is kept at appropriate levels. Insulin being the most important factor for active transport in blood glucose (BG) utilization. Well balanced glucose control facilitates ATP synthesis, thus providing necessary factors for protein utilization, cellular response to stress i.e., inflammatory process and aiding in the healing process. (Reconstructive phase). Thus, glucose control provides better response overall to the stress of disease process, allowing for stronger effective responses to all stressors. This factor may need to be assessed by HgB A1C regulation as well as albumin synthesis. The POP Factor weighting assignment can include: a first for a diabetic or medical stressors i.e., steroids but maintains BG equal to 60-120; a second for a BG>120 for more than 8 hours but less than 16 hours; a third for a BG>120 for more than 16 hours but less than 24 hours; and a fourth for a BG>120 for more than 24 hours.
  • S. H/H: Low Hemoglobin/Hematocrit (H/H) represents low oxygen caring capacity leading to decreased oxygen delivery and potentially tissue oxygenation is affected. Potentially low H/H is not represented well by StO2 measurement. Massive losses quickly will affect oxygen caring capacity. The POP Factor weighting assignment for Hemoglobin/Hematocrit (H/H) can include: a first for Hemoglobin 10/Hematocrit 30; a second for Hgb 9/Hct 27; a third for Hgb 8/Hct 24; and a fourth for Hgb 7/Hct 21.
  • T. Length of Stay (LOS): Increasing length of stay (LOS) both ICU and regular hospital increases chances of iatrogenic injury. There is a higher risk for infection, need for more procedures and constitutional stressors. Nutrition is often compromised by NPO status for tests. The POP Factor weighting assignment for length of stay can include: a first where the length of stay is 1-7 days, a second where it is 8-14 days; a third where it is 15-21 days; and a fourth is greater than 21 days.
  • U. Previous Existing Skin Injury: Previously existing wounds will only effectively heal to 80% of original strength. Thus less tolerance to new injury and stressors. Decreased tissue strength, potentially of all layers. The POP Factor weighting assignment can include: a first where old pink previously healed wounds are present; a second where there are reddened areas starting around an old wound; a third where therein is difficulty with O2 and turning and known old wounds; and a fourth where wounds open again to any stage-progression will be quick.
  • V. Albumin: Albumin holds oncotic pressure. From the dietary standpoint measurement of albumin is not a fair indicator of nutrition in a stress r/t situation due to the massive consumption and inability to use or synthesize prealbumin. However to note the concentration will quickly indicate oncotic hold. When Alb is low and fluid third spaces “water sits” between vessel and tissue. Thus, creating QS/QT at tissue level. Not allowing for distant tissue oxygenation. Also, perpetuating skin stretching effect, thinning it and increasing the stretch and strain from inside to out. The POP Factor weighting assignment can include: a first where the albumin level is 3.5 to more than 3.0; a second where the albumin level is 3.0 to more than 2.5; a third where the albumin level is 2.5 to more than 2.0; and a fourth where the albumin level is less than 2.0.
  • W. Pressure Redistributing Surface Time Line: A decrease in Braden leads to a result in surface reassessment with a possible change. (i.e., Computerized Graphing). If surfaces are not appropriate for medical condition and changes there could be additional external caustic factors. In this case, not decreasing surface area pressure. With the StO2 device the measurement of PSI and surface redistribution will be measurable and ascertainable. The POP Factor weighting assignments can include a first where there is a regular redistribution bed with Braden <14 and >12 for 12 hours; a second where there is a regular distribution bed with Braden <12 and >10 for 12 hour shift; a third where there is a regular distribution bed with Braden <10 and >8 for 12 hour shift; and a fourth where there is a regular distribution bed with Braden <8 for 12 hours or greater.
  • X. Pain or Paralysis: Critically ill patients may not move in response to pain to decreased sensation of pain or weakness. Critically ill patients may be unable to redistribute weight at all due to chemically induced paralysis or a physiologic paralysis due to injury or illness, either factor impairs movement and direct interface forces may be extensive in time. The POP Factor weighting assignment can include: a first where the patient moves himself or herself but must be reminded; a second where the patient must be turned with full assist q2 and requires mechanical loading; a third where the patient must be turned q2 due to immobility but is unstable and can only have 10-20 degree tilt and may not tolerate it and or may be associated with recovery and desat time; and a fourth where the patient is unable to turn due to severe pain or severity of critical illness and medical instability.
  • Y. StO2: StO2 can provide for the measurement and/or early detection of oxygen deprivation at a tissue level. StO2 measurement can indicate O2 delivery and consumption imbalance, but does not measure O2 consumption. Measurement of StO2 can aid in the identification of early stages of tissue injury at a micro capillary level, by measuring changes as they occur. This can aid in the earlier identification of the “at risk group.” StO2 can illustrate the pathway of skin failure, time line, cause, and affects and aid in the application of appropriate equipment and measurable measures and evaluation thereof. StO2 can aid in the identification of the invisible offenders that decrease tissue oxygenation by capturing the changes at the microcirculation level of the patient. The POP Factor weighting assignment for StO2 can include: a first for StO2 levels of WNL SO2 are less than 10 percent of normal; a second for StO2 is between 10 and 20 percent of normal; a third for StO2 is between 20 and 30 percent of normal; and a fourth for StO2 is greater than 30 percent of normal.
  • Some of the potential benefits of measuring StO2 levels of WNL established can include StO2 vs. O2 consumption. Variables that may need to be considered will be core and skin temp. Also, reperfusion time, surface and temp measurement. Especially after OR. Another one is StO2 Extraction/shunt. This can cause a false sense of comfort. * StO2−ScVo2 (SVO2)=true tissue extraction. In any high flow state i.e.: sepsis or ESLD the StO2 levels will potentially be elevated or WNL due to a hyper dynamic state. O2 extraction is decreased due to increased FTC (Velocity). In essence creating a shunt effect. This is currently supported with increased Lactate levels and decreased ph, and elevated CPK. These measurements support the idea of anaerobic oxygenation-lack of O2 at tissue level. As should be known to those of skill in the art after reading this disclosure, the uses of continuous StO2 are innumerable. These can include: ER-found down, hypotensive, hemorrhage; OR—anesthesia induction-sedation, neostick-B/P control manipulation, Bypass ICU-Pressers, CVVHD, edema, instability and inability to mobilize pt, ARDS; Wound clinic-Wound healing, Una boot application; All shock states-with possible exception of neuroleptic HD, drastic changes in tissue perfusion with large changes in circulating volume is believed to affect StO2. Similarly, the response of vasoconstriction at peripheral level and oxygen carrying capacity with decreased volume also is believed to affect StO2.
  • StO2 measurement can provide evidence based medicine (EBM) of a measured amount that will quantify as oxygen deprivation thus creating injury from inside out, e.g., deep tissue injury. Once fully available, the measurement of StO2 will help in conjunction with the system and method as described herein and will illustrate the pathway of skin failure, time line, cause and effect, appropriate equipment usage there will be measurable numbers to the invisible offenders that decrease tissue oxygenation. Caustic events and factors that can result in pressure ulcers in patients, even where appropriate medical care is provided in a competent and timely manner, will be identifiable on a per patient basis and can aid in the development of new or modified patient care procedures.
  • 3. Exemplary Assessment of Overall Assigned POP Box Weighting Value
  • After the applicable, some or all or a portion thereof, of the above various intrinsic and extrinsic factors have been reviewed and assigned a weight according to the above description, an overall POP Box Score or Value is determined by summing up all of the assigned weighted assignments. For example, where all 25 factors are considered, as shown in FIG. 2, the following care analysis can be implemented, as just one example, based assigning factors from 1 to 4 to the above 26 factors. Where the POP Box score is 0 to 25, the determined medical treatment may be that no action or treatment specific for the treatment or prevention of ulcers is required or needs to be taken. Where the weighted total patient score of 25 to 50, a determined or selected medical treatment for the prevention and treatment of ulcer's may include providing a normal turn process for the patient based on redistributing surface practice, i.e., versacare. Where the total weighted patient score is 50 to 75, a medical care provider may determine that there is a moderate risk of the patient developing pressure ulcers. In such cases, the patient's care may be adapted such that there is a low air loss overlay or surface with constant air redistribution i.e., sofcare w/pump, provided to the patient. Where the total weighted patient score is between 75 and 100, the medical care professional may determine there is a high risk for skin r/t injury. In such cases, the medical care provider may adjust the patient's treatment to anticipate the development of pressure ulcers and as such, the patient may be provided with a low air loss bed, a more frequent turn schedule and/or continual turn bed, possibly based on staff availability. Where the total weighted patient score is greater than 100, the medical care provider may determine a medical treatment for the patient may include providing the patient with a low air loss bed and with continual turning. Such determinations can also be included in medical supporting software based on predetermined criteria and ratings and aid in providing the medical care professional with recommended treatments.
  • Of course, it should be understood by one skilled in the art and practice as a health care provider, that these ranges and the implications of these ranges can be adjusted and still be within the scope of the present disclosure.
  • As understood to those in the art having reviewed this present disclosure, the systems and methods described herein and claimed or claimable by this disclosure, provide a medical aid to healthcare and medical practitioners. Nothing in this present disclosure or claims specifically identifies the particular recommended treatments based on the POP Box scores or in anyway limits or restricts those recommended treatments. The determined recommended treatments of the present systems and methods are determined using the POP Box scores from the experience of the medical care providers and by standards that can be determined overall time based on the best practices in the medical profession as determined in view of the determined POP Box scores. Such determined treatments can vary by medical care provider and are expected to change over time.
  • 4. Benefits in Various Embodiments Over the Prior Art
  • The POP box can improve medical diagnosis and treatment for a variety of medical conditions and needs. The POP Box systems and methods as described herein can, in some embodiments, help to expose variables, events and conditions that are caustic to skin integrity that have not previously been considered as risk factors. The POP Box system and methods can in other embodiments, help guide the prevention and care required with the increase in risk factors such as changes in medical treatment equipment and modification to patient turn schedules. In other embodiments, the POP Box system and method can potentially increase medical care provider patient interventions for guiding appropriate staffing needs for advanced preventative care. In some other embodiments, the POP Box system and method can establish, or help the care givers establish, a fixed set of risk variables that can be utilized for risk assessment and allocation by various stakeholders, by quantifying and organizing the factors so they can be understood and tabulated. In other embodiments, the POP Box system can establish factors or help the care giver in establishing the factors, assessment and guidelines for determining the severity of particular patient status or underlying illness and conditions for inclusion in assessing medical treatments and life lengthening decisions.
  • 5. POP Box Exemplary System Embodiment
  • As will be understood to one skilled in the art, the POP Box system and method as described herein can be implemented in whole or in part in an automated manner, including within a computer system or systems, and in particular as computer implemented instructions having computer executable instructions for performing some or all of the methods disclosed herein. Referring to FIG. 3, an operating environment for an exemplary embodiment of a Pressure, Oxygenation, and Perfusion (POP) Box system and method including one or more components or modules thereof is a computer system 300 with a computer 302 that comprises at least one high speed processing System (CPU) 304, in conjunction with a memory system 306 interconnected with at least one bus structure 308, an input device 310, and an output device 312. These elements are interconnected by at least one bus structure 312.
  • The illustrated CPU 304 is of familiar design and includes an arithmetic logic unit (ALU) 314 for performing computations, a collection of registers 314 for temporary storage of data and instructions, and a control System 316 for controlling operation of the system 300. Any of a variety of processors, including at least those from Digital Equipment, Sun, MIPS, Motorola, NEC, Intel, Cyrix, AMD, HP, and Nexgen, is equally preferred for the CPU 304. The illustrated embodiment of the system operates on an operating system designed to be portable to any of these processing platforms.
  • The memory system 306 generally includes high-speed main memory 320 in the form of a medium such as random access memory (RAM) and read only memory (ROM) semiconductor devices, and secondary storage 322 in the form of long term storage mediums such as floppy disks, hard disks, tape, CD-ROM, flash memory, etc. and other devices that store data using electrical, magnetic, optical or other recording media. The main memory 320 also can include video display memory for displaying images through a display device. Those skilled in the art will recognize that the memory system 306 can comprise a variety of alternative components having a variety of storage capacities and can include a subscriber identity or information module (SIM) such as a GSM SIM Card, in one embodiment.
  • The input device 310 and output device 312 are also familiar. The input device 310 typically comprises a keyboard, but can also include a mouse, a touch screen, a physical transducer (e.g. a microphone), etc. and is interconnected to the computer 302 via an input interface 324. The output device 312 can comprise a display but can also include a printer, a transducer (e.g. a speaker), etc, and be interconnected to the computer 302 via an output interface 326. Some devices, such as a network adapter or a modem, can be used as input and/or output devices.
  • As is familiar to those skilled in the art, the computer system 300 further includes an operating system and at least one application program. The operating system is the set of software which controls the computer system's operation and the allocation of resources. The application program is the set of software that performs a task desired by the user, using computer resources made available through the operating system. Both are resident in the illustrated memory system 306.
  • In accordance with the practices of persons skilled in the art of computer programming, the present system is described below with reference to symbolic representations of operations that are performed by the computer system 300. Such operations are sometimes referred to as being computer-executed. It will be appreciated that the operations which are symbolically represented include the manipulation by the CPU 304 of electrical signals representing data bits and the maintenance of data bits at memory locations in the memory system 306, as well as other processing of signals. The memory locations where data bits are maintained are physical locations that have particular electrical, magnetic, or optical properties corresponding to the data bits. The system can be implemented in a program or programs, comprising a series of instructions stored on a computer-readable medium. The computer-readable medium can be any of the devices, or a combination of the devices, described above in connection with the memory system 306.
  • Referring now to FIG. 4, a method for assessing a patient for pressure related skin injury risk and recommended treatment is illustrated. As shown in this exemplary embodiment, the method starts 402 with a measurement of a patient's skin pressure 404. The measured skin pressure is input at 406 into a computer system such as system 300 via an input device 310 and stored in memory 306. The system 300 includes computer implementable instructions for assigning a rating in 408 to skin pressure based on predetermined allocations such as those described above by way of example. The assigned skin pressure rating of 408 is also stored in memory 306. The tissue oxygenation of the patient is measured in 410 and entered and received by system 300 in 412. The system assigned a tissue oxygenation rating in 414 and both the measured tissue oxygenation and the assign tissue oxygenation rating are stored in memory 306. The perfusion is measured in 416 and received by the system 300 in 418. The system 300 assigns a perfusion rating in 420. Both the measured perfusion and the assigned perfusion rating are stored in memory 306. Of course one skilled in the art will understand that the order of processes 404 to 420 can be changed in any manner and still be within the scope of the present method. Additionally, as described above, these three variables of skin pressure, tissue oxygenation, and perfusion are exemplary variables or factors. Additional or different variables and factors can be implemented by some embodiments of the method and still be within the scope of the present disclosure.
  • Next the system 300 sums the available factor ratings in 422 to determine a POP Box Score. Of course, while summing is identified as one method or algorithm for determining the POP Box Score, those skilled in the art will understand that other methods and algorithms can be utilized to determine the POP Box Score of the various selected and/or included factors and still be within the scope of the present disclosure. The total POP Box Score is provided to a comparison process of 424 for comparison to determine the risks to the patient for pressure related skin injury and determining a recommended treatment. A plurality of risks for pressure related skin injury and recommended treatments are predetermined and scored by medical professionals and stored in memory 306. Each of these risks and recommended treatments can include one or more assigned POP Box Score. The patient's POP Box score of process 422 is compared in process 424 with the predetermined or allocated ratings obtained from process 426 in process 428 and a recommended treatment is determined in 430 based on the comparison process 424 and the determined risk of 428. The determined recommended treatment of 430 can be presented to the medical care provider as an output of the system 300 such as inclusion in a report or as a presentation at the output interface 312. The medical care provider can be presented with the determined risk 428 and recommended treatment 430 and can also be presented with some or all of the stored measurements and assigned ratings for final selection by the medical care provider of the treatment of the patient. The determined recommended treatment is also stored in memory 306. The process ends at 432.
  • When describing elements or features and/or embodiments thereof, the articles “a”, “an”, “the”, and “said” are intended to mean that there are one or more of the elements or features. The terms “comprising”, “including”, and “having” are intended to be inclusive and mean that there may be additional elements or features beyond those specifically described.
  • Those skilled in the art will recognize that various changes can be made to the exemplary embodiments and implementations described above without departing from the scope of the disclosure. Accordingly, all matter contained in the above description or shown in the accompanying drawings should be interpreted as illustrative and not in a limiting sense.
  • It is further to be understood that the processes or steps described herein are not to be construed as necessarily requiring their performance in the particular order discussed or illustrated. It is also to be understood that additional or alternative processes or steps may be employed.

Claims (25)

1. A system for assessing a patient for pressure related skin injury risk and recommended treatment comprising:
a memory;
an input device;
an output device; and
a processor,
wherein the memory and processor include computer executable instructions for implementing the method of
receiving a measured skin pressure of the patient;
assigning a rating responsive to the received skin pressure measurement;
receiving a measured tissue oxygenation of the patient;
assigning a rating responsive to the received oxygenation measurement;
receiving a measured perfusion of the patient;
assigning a rating responsive to the received perfusion measurement;
summing the skin pressure, tissue oxygenation and perfusion ratings to obtain a POP Box score;
determining a risk of pressure related skin injury for the patient in response to the POP Box score; and
determining a recommended treatment from among a plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury.
2. The system of claim 1 wherein the computer executable instructions for receiving measured tissue oxygenation include receiving measured tissue oxygenation as determined by StO2 and wherein the assigned rating for oxygenation is responsive to the received StO2 measurement.
3. The system of claim 2 wherein assigning a rating for the measured tissue oxygenation based on StO2 includes:
assigning a first StO2 rating where StO2 levels of WNL SO2 are less than 10 percent of normal;
assigning a second StO2 rating where StO2 is between 10 and 20 percent of normal;
assigning a third StO2 rating where StO2 is between 20 and 30 percent of normal; and
assigning a fourth StO2 rating where StO2 is greater than 30 percent of normal.
4. The system of claim 1 wherein receiving the measured tissue oxygenation includes one or more of the following processes:
receiving a measurement of a venous oxygen saturation (SvO2) or a central venous oxygen saturation (SvcO2) and assigning a rating responsive to the measured SvO2 or SvcO2;
receiving a measurement of a ratio of arterial oxygen concentration to the fraction of inspired oxygen (P/F ratio) of the patient and assigning a rating responsive to the measured P/F ratio;
receiving a measurement of a desaturation recovery time of oxygen saturation (SpO2) of the patient and assigning a rating responsive to the measured (SpO2);
receiving a measurement of a blood glucose of a patient and assigning a rating responsive to the measured blood glucose;
receiving a hemogolin/hematocrit (H/H) measurement of the patient and assigning a rating responsive to the measured H/H;
receiving a measured vital sign of the patient including the blood pressure and heart rate and assigning a rating responsive to the measured vital sign;
receiving a Cardiac Index (CI), Cardiac Output (CO), or Stroke Volume (SV) measurement of the patient and assigning a rating responsive to the measured CI, CO or SV;
receiving a measured or identified presence of one or more pressor agents and assigning a rating responsive to the measured or identified pressor agent; and
receiving an identified maceration of the patient and assigning a rating responsive to the identified maceration.
5. The system of claim 1 wherein receiving measured skin pressure includes one or more of the following processes:
determining a Braden Score and assigning a rating responsive to the Braden Score determining an age of the patient and assigning a rating responsive to the determining;
receiving a determined presence of steroid use by the patient and assigning a rating responsive to the determining;
receiving a measured Edema of the patient and assigning a rating responsive to the measuring;
receiving a determined presence of pain or paralysis of the patient and assigning a rating responsive to the determining;
receiving a measured Albumin level of the patient and assigning a rating responsive to the measuring;
receiving an identified presence of one or more mechanical apparatus associated with the patient wherein in the assigning is responsive to the number of identified apparatus present; and
receiving a determined pressure redistribution surface time of the patient and assigning a rating responsive to the determining.
6. The system of claim 1 wherein receiving a measuring perfusion includes one or more of the following processes:
receiving a measured vital sign of the patient including the blood pressure and heart rate and assigning a rating responsive to the measuring;
receiving a measured Cardiac Index (CI), Cardiac Output (CO), or Stroke Volume (SV) of the patient and assigning a rating responsive to the measuring;
receiving an identified presence of one or more pressor agents and assigning a rating responsive to the identifying; and
receiving an identified maceration of the patient and assigning a rating responsive to the identifying.
7. The system of claim 1 wherein receiving measured skin pressure, oxygenation and perfusion includes one or more of the following processes:
receiving a determined body mass index of the patient and assigning a rating responsive to the determining;
receiving a determination of whether the patient was found in a down position prior to evaluation and assigning a rating responsive to the determining;
receiving a determined operating room variable of the patient wherein in the assigning is responsive to the number of such operating room variables present;
receiving a determined presence of one or more disease processes present in the patient wherein in the assigning is responsive to the number of such present disease processes;
receiving a determined length of stay for both ICU and regular hospital stays for the patient and assigning a rating responsive to the determining;
receiving an evaluation of an emergency room procedure experience by the patient and assigning a rating responsive to the evaluating; and
receiving an identified previous or existing skin injury of the patient and assigning a rating responsive to the identifying.
8. The system of claim 1 wherein determining a recommended treatment for the patient in response to the determined risk of pressure related skin injury includes an assigning of a rating from 1 to 4 for each assignment; and
wherein the POP Box score is determined to be in the range of 0 to 25, the determined recommended treatment is taking no action;
wherein the POP Box score is determined to be in the range of 25 to 50, the determined recommended treatment is providing normal turn on redistributing surface practice;
wherein the POP Box score is determined to be in the range of 50 to 75, the determined recommended treatment is adapting care of the patient for low air loss overlay or surface with constant air redistribution;
wherein the POP Box score is determined to be in the range of 75 to 100, the determined recommended treatment is providing the patient with a low air loss bed, providing a more frequent turn schedule and/or providing for continual turn bed; and
wherein the POP Box score is determined to be greater than 100, the determined recommended treatment is providing the patient with a low air loss bed with continual turning.
9. Computer readable medium having computer executable instructions for assessing a patient for pressure related skin injury risk and recommended treatment, the computer executable instructions performing the method comprising:
receiving a measured skin pressure of the patient;
assigning a rating responsive to the received skin pressure measurement;
receiving a measured oxygenation of the patient;
assigning a rating responsive to the received oxygenation measurement;
receiving a measured perfusion of the patient;
assigning a rating responsive to the received perfusion measurement;
summing the skin pressure, oxygenation and perfusion ratings to obtain a POP Box score;
determining a risk of pressure related skin injury for the patient in response to the POP Box score; and
determining a recommended treatment from among a plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury.
10. The computer readable medium of claim 9 wherein the computer executable instructions for oxygenation include receiving measured tissue oxygenation as determined by StO2 and wherein the assigning a rating for tissue oxygenation is responsive to the received StO2 measurement.
11. The computer readable medium of claim 9 wherein the computer executable instructions assigning a rating for the measured oxygenation based on StO2 includes:
assigning a first StO2 rating where StO2 levels of WNL SO2 are less than 10percent of normal;
assigning a second StO2 rating where StO2 is between 10 and 20 percent of normal;
assigning a third StO2 rating where StO2 is between 20 and 30 percent of normal; and
assigning a fourth StO2 rating where StO2 is greater than 30 percent of normal.
12. The computer readable medium of claim 9 wherein the computer executable instructions for oxygenation includes one or more of the following processes:
receiving a measurement of a venous oxygen saturation (SvO2) or central venous oxygen saturation (SvcO2) and assigning a rating responsive to the measured SvO2 or SvcO2;
receiving a measurement of a ratio of arterial oxygen concentration to the fraction of inspired oxygen (P/F ratio) of the patient and assigning a rating responsive to the measured P/F ratio;
receiving a measurement of a desaturation recovery time of oxygen saturation (SpO2) of the patient and assigning a rating responsive to the measured SpO2;
receiving a measurement of a blood glucose of a patient and assigning a rating responsive to the measured blood glucose;
receiving a hemogolin/hematocrit (H/H) measurement of the patient and assigning a rating responsive to the measured H/H;
receiving a measured vital sign of the patient including the blood pressure and heart rate and assigning a rating responsive to the measured vital sign;
receiving a Cardiac Index (CI), Cardiac Output (CO), or Stroke Volume (SV) of the patient and assigning a rating responsive to the measured CI, CO or SV;
receiving a measured or identified presence of one or more pressor agent and assigning a rating responsive to the measured or identified pressor agent; and
receiving an identified maceration of the patient and assigning a rating responsive to the identified maceration.
13. The computer readable medium of claim 9 wherein the computer executable instructions for receiving a measured skin pressure and assigning a rating responsive to the received skin pressure measurement include one or more of the following combination processes:
determining a Braden Score and assigning a rating responsive to the Braden Score determining an age of the patient and assigning a rating responsive to the determining;
receiving a determined steroid use by the patient and assigning a rating responsive to the determining;
receiving a measured Edema of the patient and assigning a rating responsive to the measuring;
receiving a determined presence of pain or paralysis of the patient and assigning a rating responsive to the determining;
receiving an Albumin level of the patient and assigning a rating responsive to the measuring;
receiving an identified presence of one or more mechanical apparatus associated with the patient wherein in the assigning is responsive to the number of identified apparatus present; and
receiving a determined pressure redistribution surface time of the patient and assigning a rating responsive to the determining.
14. The computer readable medium of claim 9 wherein the computer executable instructions for receiving a measured perfusion and assignment a rating to the received perfusion measurement includes one or more of the following combination processes:
receiving a measured vital sign of the patient including the blood pressure and heart rate and assigning a rating responsive to the measuring;
receiving a measured Cardiac Index (CI), Cardiac Output (CO), or Stroke Volume (SV) of the patient and assigning a rating responsive to the measuring;
receiving an identified presence of one or more pressor agent and assigning a rating responsive to the identifying; and
receiving an identified maceration of the patient and assigning a rating responsive to the identifying.
15. The computer readable medium of claim 9 wherein the computer executable instructions includes one or more of the following processes:
receiving a determined a body mass index of the patient and assigning a rating responsive to the determining;
receiving a determination of whether the patient was found in a down position prior to evaluation and assigning a rating responsive to the determining;
receiving a determined operating room variable of the patient wherein in the assigning is responsive to the number of such operating room variables present;
receiving a determined presence of one or more disease processes present in the patient wherein in the assigning is responsive to the number of such present disease processes;
receiving a determined length of stay for both ICU and regular hospital stays for the patient and assigning a rating responsive to the determining;
receiving an evaluated emergency room procedure experience by the patient and assigning a rating responsive to the evaluating; and
receiving an identified previous or existing skin injury of the patient and assigning a rating responsive to the identifying.
16. The computer readable medium of claim 9 wherein the computer executable instructions for determining a recommended treatment from among a plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury includes the following:
assigning a rating from 1 to 4 in each assigning step, and:
wherein the POP Box score is determined to be in a range of 0 to 25, and the determined recommended treatment is taking no action;
wherein the POP Box score is determined to be in the range of 25 to 50, and the determined recommended treatment is providing normal turn on redistributing surface practice;
wherein the POP Box score is determined to be in the range of 50 to 75, and the determined recommended treatment is adapting care of the patient for low air loss overlay or surface with constant air redistribution;
wherein the POP Box score is determined to be in the range of 75 and 100, and the determined recommended treatment is providing the patient with a low air loss bed, provide a more frequent turn schedule and/or continual turn bed; and
wherein the POP Box score is determined to be greater than 100, and the determined recommended treatment is providing the patient with a low air loss bed with continual turning.
17. A method for assessing a patient for pressure related skin injury risk and recommended treatment comprising:
measuring skin pressure of the patient and assigning a rating responsive to the skin pressure measurement;
measuring tissue oxygenation of the patient and assigning a rating responsive to the tissue oxygenation measurement;
measuring perfusion of the patient and assigning a rating responsive to the perfusion measurement;
summing the skin pressure, tissue oxygenation and perfusion ratings to obtain a POP Box score;
determining a risk of pressure related skin injury for the patient in response to the POP Box score; and
determining a recommended treatment from among a plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury.
18. The method of claim 17 wherein measuring tissue oxygenation includes measuring StO2.
19. The method of claim 18 wherein assigning a rating for the measured StO2 includes:
assigning a first StO2 rating where StO2 levels of WNL SO2 are less than 10 percent of normal;
assigning a second StO2 rating where StO2 is between 10 and 20 percent of normal;
assigning a third StO2 rating where StO2 is between 20 and 30 percent of normal; and
assigning a fourth StO2 rating where StO2 is greater than 30 percent of normal.
20. The method of claim 17 wherein measuring tissue oxygenation includes one or more of the following processes:
measuring a venous oxygen saturation (SvO2) or central venous oxygen saturation (SvcO2) and assigning a rating responsive to the measuring;
measuring a ratio of arterial oxygen concentration to the fraction of inspired oxygen (P/F ratio) of the patient and assigning a rating responsive to the measuring;
measuring a desaturation recovery time of oxygen saturation (SpO2) of the patient and assigning a rating responsive to the measuring;
measuring a blood glucose of a patient and assigning a rating responsive to the measuring;
measuring a hemogolin/hematocrit (H/H) of the patient and assigning a rating responsive to the measuring;
measuring a vital sign of the patient including the blood pressure and heart rate and assigning a rating responsive to the measuring;
measuring a CI or CO of the patient and assigning a rating responsive to the measuring;
identifying a presence of one or more pressor agent and assigning a rating responsive to the identifying; and
identifying maceration of the patient and assigning a rating responsive to the identifying.
21. The method of claim 17 wherein measuring skin pressure includes one or more of the following processes:
determining a Braden Score and assigning a rating responsive to the Braden Score determining an age of the patient and assigning a rating responsive to the determining;
determining steroid use by the patient and assigning a rating responsive to the determining;
measuring an Edema of the patient and assigning a rating responsive to the measuring;
determining a presence of pain or paralysis of the patient and assigning a rating responsive to the determining;
measuring an Albumin level of the patient and assigning a rating responsive to the measuring;
identifying a presence of one or more mechanical apparatus associated with the patient wherein the assigning is responsive to the number of identified apparatus present; and
determining a pressure redistribution surface time of the patient and assigning a rating responsive to the determining.
22. The method of claim 17 wherein measuring perfusion includes one or more of the following processes:
measuring a vital sign of the patient including the blood pressure and heart rate and assigning a rating responsive to the measuring;
measuring a Cardiac Index (CI), Cardiac Output (CO), or Stroke Volume (SV) of the patient and assigning a rating responsive to the measuring;
identifying a presence of one or more pressor agent and assigning a rating responsive to the identifying; and
identifying maceration of the patient and assigning a rating responsive to the identifying.
23. The method of claim 17 wherein measuring skin pressure, tissue oxygenation and perfusion includes one or more of the following processes:
determining a body mass index of the patient and assigning a rating responsive to the determining;
determining whether the patient was found in a down position prior to evaluation and assigning a rating responsive to the determining;
determining an operating room variable of the patient wherein in the assigning is responsive to the number of such operating room variables present;
determining a presence of one or more disease processes present in the patient wherein in the assigning is responsive to the number of such present disease processes;
determining length of stay for both ICU and regular hospital stays for the patient and assigning a rating responsive to the determining;
evaluating an emergency room procedure experience by the patient and assigning a rating responsive to the evaluating; and
identifying previous or existing skin injury of the patient and assigning a rating responsive to the identifying.
24. The method of claim 17 wherein determining a recommended treatment for the patient in response to the determined risk of pressure related skin injury includes the following:
wherein each assigning includes assigning a rating from 1 to 4; and
wherein the POP Box score is determined to be in the range of 0 to 25, determining a recommended treatment includes taking no action;
wherein the POP Box score is determined to be in the range of 25 to 50, determining a recommended treatment includes providing normal turn on redistributing surface practice;
wherein the POP Box score is determined to be in the range of 50 to 75, determining a recommended treatment includes adapting care of the patient for low air loss overlay or surface with constant air redistribution;
wherein the POP Box score is determined to be in the range of 75 and 100, determining a recommended treatment includes providing the patient with a low air loss bed, provide a more frequent turn schedule and/or continual turn bed; and
wherein the POP Box score is determined to be in the range of 100, determining a recommended treatment from among a plurality of recommended treatments includes providing the patient with a low air loss bed with continual turning.
25. The method of claim 17, further comprising:
in a computer system configured for assessing a patient for pressure related skin injury risk and recommended treatment having a memory, an input device, an output device, a processor, and wherein the memory and processor include computer executable instructions for implementing the method including
receiving the measured skin pressure of the patient and the assigning of the rating responsive to the skin pressure measurement;
receiving the measured tissue oxygenation of the patient and the assigning of the rating responsive to the tissue oxygenation measurement;
receiving the measured perfusion of the patient and the assigning of the rating responsive to the perfusion measurement;
and the summing of the skin pressure, tissue oxygenation and perfusion ratings to obtain a POP Box score and the determining of the risk of pressure related skin injury for the patient in response to the POP Box score and the determining of a recommended treatment from among the plurality of recommended treatments for the patient in response to the determined risk of pressure related skin injury.
US12/793,514 2009-06-03 2010-06-03 Pop box methods and systems for assessing risk of pressure related skin injury and determining a recommended treatment thereof Abandoned US20100312076A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US12/793,514 US20100312076A1 (en) 2009-06-03 2010-06-03 Pop box methods and systems for assessing risk of pressure related skin injury and determining a recommended treatment thereof
US15/862,358 US11172871B2 (en) 2009-06-03 2018-01-04 Method of treatment of pressure related skin injury
US17/526,790 US20220071551A1 (en) 2009-06-03 2021-11-15 Method and system for pressure related skin injury risk assessment and treatment

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18366709P 2009-06-03 2009-06-03
US12/793,514 US20100312076A1 (en) 2009-06-03 2010-06-03 Pop box methods and systems for assessing risk of pressure related skin injury and determining a recommended treatment thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/862,358 Continuation US11172871B2 (en) 2009-06-03 2018-01-04 Method of treatment of pressure related skin injury

Publications (1)

Publication Number Publication Date
US20100312076A1 true US20100312076A1 (en) 2010-12-09

Family

ID=43301219

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/793,514 Abandoned US20100312076A1 (en) 2009-06-03 2010-06-03 Pop box methods and systems for assessing risk of pressure related skin injury and determining a recommended treatment thereof
US15/862,358 Active US11172871B2 (en) 2009-06-03 2018-01-04 Method of treatment of pressure related skin injury

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/862,358 Active US11172871B2 (en) 2009-06-03 2018-01-04 Method of treatment of pressure related skin injury

Country Status (1)

Country Link
US (2) US20100312076A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130198207A1 (en) * 2012-01-26 2013-08-01 University Of Rochester Integrated multi-criteria decision support framework
US20130281804A1 (en) * 2012-04-20 2013-10-24 Life Support Technologies, Inc. Methods and systems for monitoring a patient to reduce the incidence of pressure ulcers
US20140304915A1 (en) * 2013-04-11 2014-10-16 Charles A. Lachenbruch Occupant Support Adapted to Manage Pressure Ulcer Risk and Associated Risk Management Methods
US9135804B2 (en) * 2012-03-23 2015-09-15 Persimmon Scientific, Inc. Systems and methods for assessing risks of pressure ulcers
US20150371522A1 (en) * 2013-01-28 2015-12-24 Sensimat Systems Inc. Multi-Station System for Pressure Ulcer Monitoring and Analysis
EP3509071A1 (en) * 2018-01-08 2019-07-10 Firstbeat Technologies Oy A method and an apparatus for determining injury risk of a person based on physiological data
EP3653110A1 (en) * 2018-11-16 2020-05-20 Hill-Rom Services, Inc. Systems and methods for determining an objective pressure injury score
US11751769B2 (en) * 2017-03-22 2023-09-12 Modulated Imaging, Inc. Systems and methods for assessing diabetic circulatory complications

Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287253B1 (en) * 1999-06-25 2001-09-11 Sabolich Research & Development Pressure ulcer condition sensing and monitoring
US20020082485A1 (en) * 1995-06-07 2002-06-27 Faithfull Nicholas Simon System and methods for measuring oxygenation parameters
US20030171954A1 (en) * 2002-02-01 2003-09-11 Tempur World, Inc. Method of managing the provision of healthcare and system for effecting same
US20040059199A1 (en) * 2002-09-04 2004-03-25 Thomas Pamela Sue Wound assessment and monitoring apparatus and method
US20050165284A1 (en) * 2002-03-25 2005-07-28 Amit Gefen Method and system for determining a risk of ulcer onset
US20060149154A1 (en) * 2002-10-17 2006-07-06 Stephens Frederick R N Method and apparatus for measuring tissue perfusion
US20060253160A1 (en) * 2003-03-12 2006-11-09 Transoma Medical, Inc. Devices and methods for detecting and treating inadequate tissue perfusion
US20070016079A1 (en) * 2005-04-04 2007-01-18 Freeman Jenny E Hyperspectral imaging in diabetes and peripheral vascular disease
US20080098333A1 (en) * 2006-06-01 2008-04-24 Simquest Llc Method and apparatus for collecting and analyzing surface wound data
US20090076732A1 (en) * 2007-08-30 2009-03-19 Georgia Tech Research Corporation Systems and methods for the analysis of mechanical properties of materials
US7536214B2 (en) * 2005-10-26 2009-05-19 Hutchinson Technology Incorporated Dynamic StO2 measurements and analysis
US7553285B2 (en) * 2003-05-05 2009-06-30 Vioptix Inc. Diagnosing peripheral vascular disease by monitoring oxygen saturation changes during an accumulation phase
US7570979B2 (en) * 2004-03-30 2009-08-04 Philip George Cooper Methods and apparatus for patient monitoring
US7569017B2 (en) * 2003-05-05 2009-08-04 Vioptix Inc. Diagnosing peripheral vascular disease by monitoring oxygen saturation changes during an ischemia phase
US7582060B2 (en) * 2003-05-05 2009-09-01 Vioptix Inc. Diagnosing peripheral vascular disease by monitoring oxygen saturation changes during a hyperemia phase
US7613489B2 (en) * 2004-05-18 2009-11-03 Hutchinson Technology Incorporated Optimized wavelength gap for improved StO2 measurement
US20100210931A1 (en) * 2008-04-04 2010-08-19 Modulate Imaging Inc. Method for performing qualitative and quantitative analysis of wounds using spatially structured illumination
US20110124987A1 (en) * 2008-04-21 2011-05-26 Drexel University Methods for Measuring Changes in Optical Properties of Wound Tissue and Correlating Near Infrared Absorption (FNIR) and Diffuse Reflectance Spectroscopy Scattering (DRS) With Tissue Neovascularization and Collagen Concentration to Determine Whether Wound is Healing
US20110144462A1 (en) * 2008-03-19 2011-06-16 Rick Lifsitz Miniaturized multi-spectral imager for real-time tissue oxygenation measurement
US8116838B2 (en) * 2007-11-27 2012-02-14 Carnegie Mellon University Medical device for diagnosing pressure ulcers

Patent Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082485A1 (en) * 1995-06-07 2002-06-27 Faithfull Nicholas Simon System and methods for measuring oxygenation parameters
US6287253B1 (en) * 1999-06-25 2001-09-11 Sabolich Research & Development Pressure ulcer condition sensing and monitoring
US20030171954A1 (en) * 2002-02-01 2003-09-11 Tempur World, Inc. Method of managing the provision of healthcare and system for effecting same
US20050165284A1 (en) * 2002-03-25 2005-07-28 Amit Gefen Method and system for determining a risk of ulcer onset
US20040059199A1 (en) * 2002-09-04 2004-03-25 Thomas Pamela Sue Wound assessment and monitoring apparatus and method
US20060149154A1 (en) * 2002-10-17 2006-07-06 Stephens Frederick R N Method and apparatus for measuring tissue perfusion
US20060253160A1 (en) * 2003-03-12 2006-11-09 Transoma Medical, Inc. Devices and methods for detecting and treating inadequate tissue perfusion
US7553285B2 (en) * 2003-05-05 2009-06-30 Vioptix Inc. Diagnosing peripheral vascular disease by monitoring oxygen saturation changes during an accumulation phase
US7582060B2 (en) * 2003-05-05 2009-09-01 Vioptix Inc. Diagnosing peripheral vascular disease by monitoring oxygen saturation changes during a hyperemia phase
US7569017B2 (en) * 2003-05-05 2009-08-04 Vioptix Inc. Diagnosing peripheral vascular disease by monitoring oxygen saturation changes during an ischemia phase
US7570979B2 (en) * 2004-03-30 2009-08-04 Philip George Cooper Methods and apparatus for patient monitoring
US7613489B2 (en) * 2004-05-18 2009-11-03 Hutchinson Technology Incorporated Optimized wavelength gap for improved StO2 measurement
US20070016079A1 (en) * 2005-04-04 2007-01-18 Freeman Jenny E Hyperspectral imaging in diabetes and peripheral vascular disease
US7536214B2 (en) * 2005-10-26 2009-05-19 Hutchinson Technology Incorporated Dynamic StO2 measurements and analysis
US20080098333A1 (en) * 2006-06-01 2008-04-24 Simquest Llc Method and apparatus for collecting and analyzing surface wound data
US20090076732A1 (en) * 2007-08-30 2009-03-19 Georgia Tech Research Corporation Systems and methods for the analysis of mechanical properties of materials
US8116838B2 (en) * 2007-11-27 2012-02-14 Carnegie Mellon University Medical device for diagnosing pressure ulcers
US20110144462A1 (en) * 2008-03-19 2011-06-16 Rick Lifsitz Miniaturized multi-spectral imager for real-time tissue oxygenation measurement
US20100210931A1 (en) * 2008-04-04 2010-08-19 Modulate Imaging Inc. Method for performing qualitative and quantitative analysis of wounds using spatially structured illumination
US20110124987A1 (en) * 2008-04-21 2011-05-26 Drexel University Methods for Measuring Changes in Optical Properties of Wound Tissue and Correlating Near Infrared Absorption (FNIR) and Diffuse Reflectance Spectroscopy Scattering (DRS) With Tissue Neovascularization and Collagen Concentration to Determine Whether Wound is Healing

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
Curley et al. "Predicting pressure ulcer risk in pediatric patients: the Braden Q Scale." Nurs Res. 2003 Jan-Feb;52(1):22-33. *
Curley et al. "Pressure ulcers in pediatric intensive care: incidence and associated factors." Pediatr Crit Care Med. 2003 Jul;4(3):284-90. *
Hartford Institute for Geriatric Nursing. "Preventing pressure ulcers and skin tears. In: Evidence-based geriatric nursing protocols for best practice." January 2008. 7 pages. *
Hutchinson Technology BioMeasurement Division. "StO2: Tissue Oxygen Saturation." 2013. www.htibiomeasurement.com/technology/sto2_tissue_oxygen_saturation/ *
Jonsson et al. "Tissue oxygenation, anemia, and perfusion in relation to wound healing in surgical patients." Ann Surg. 1991 November; 214(5): 605-613. *
Keller et al. "Pressure ulcers in intensive care patients: a review of risks and prevention." Intensive Care Med. 2002 Oct;28(10):1379-88. Epub 2002 Sep 7. *
Lamberts, SWJ. "The Value of Pressure Ulcer Risk Assessment and Interface Pressure Measurements in Patients: A nursing perspective." 2005. 160 pages. *
Maklebust, J. "Pressure Ulcers - Etiology and Prevention." Nurs Clin North Am. 1987 Jun;22(2):359-77. *
Mayo Clinic. "Bedsores (Pressure Sores)." 12 July 2008. http://web.archive.org/web/20080712041519/http://www.mayoclinic.com/health/bedsores/DS00570/DSECTION=risk-factors *
Papanikolaou et al. "Risk assessment scales for pressure ulcers: a methodological review." Int J Nurs Stud. 2007 Feb;44(2):285-96. Epub 2006 Dec 4. *
Royal College of Nursing. "Pressure Ulcer Risk Assessment and Prevention: Recommendations." Clinical Practice Guidelines. April 2001. *
Senturan et al. "The relationship among pressure ulcers, oxygenation, and perfusion in mechanically ventilated patients in an intensive care unit." J Wound Ostomy Continence Nurs. 2009 Sep-Oct;36(5):503-8. *
Wywialowski EF. "Tissue perfusion as a key underlying concept of pressure ulcer development and treatment." J Vasc Nurs. 1999 Mar;17(1):12-16. *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9058354B2 (en) * 2012-01-26 2015-06-16 University Of Rochester Integrated multi-criteria decision support framework
US20130198207A1 (en) * 2012-01-26 2013-08-01 University Of Rochester Integrated multi-criteria decision support framework
US9135804B2 (en) * 2012-03-23 2015-09-15 Persimmon Scientific, Inc. Systems and methods for assessing risks of pressure ulcers
US20130281804A1 (en) * 2012-04-20 2013-10-24 Life Support Technologies, Inc. Methods and systems for monitoring a patient to reduce the incidence of pressure ulcers
US10524721B2 (en) * 2012-04-20 2020-01-07 Life Support Technologies, Inc. Methods and systems for monitoring a patient to reduce the incidence of pressure ulcers
US20150371522A1 (en) * 2013-01-28 2015-12-24 Sensimat Systems Inc. Multi-Station System for Pressure Ulcer Monitoring and Analysis
US20140304915A1 (en) * 2013-04-11 2014-10-16 Charles A. Lachenbruch Occupant Support Adapted to Manage Pressure Ulcer Risk and Associated Risk Management Methods
US11751769B2 (en) * 2017-03-22 2023-09-12 Modulated Imaging, Inc. Systems and methods for assessing diabetic circulatory complications
EP3509071A1 (en) * 2018-01-08 2019-07-10 Firstbeat Technologies Oy A method and an apparatus for determining injury risk of a person based on physiological data
US11482333B2 (en) 2018-01-08 2022-10-25 Firstbeat Analytics Oy Method and an apparatus for determining injury risk of a person based on physiological data
CN111195180A (en) * 2018-11-16 2020-05-26 希尔-罗姆服务公司 System and method for determining a target pressure injury score and modifying a treatment plan based thereon
US11672470B2 (en) 2018-11-16 2023-06-13 Hill-Rom Services, Inc. Systems and methods for determining an objective pressure injury score and altering a treatment plan based on the same
EP3653110A1 (en) * 2018-11-16 2020-05-20 Hill-Rom Services, Inc. Systems and methods for determining an objective pressure injury score

Also Published As

Publication number Publication date
US11172871B2 (en) 2021-11-16
US20180125411A1 (en) 2018-05-10

Similar Documents

Publication Publication Date Title
US11172871B2 (en) Method of treatment of pressure related skin injury
Tisherman et al. Clinical practice guideline: endpoints of resuscitation
JP6785339B2 (en) Evaluation of circulatory failure
McKinley et al. Normal versus supranormal oxygen delivery goals in shock resuscitation: the response is the same
Stordeur et al. The importance of repeated risk assessment for pressure sores in cardiovascular surgery
Stewart et al. The compensatory reserve index following injury: results of a prospective clinical trial
Mesquida et al. Thenar oxygen saturation measured by near infrared spectroscopy as a noninvasive predictor of low central venous oxygen saturation in septic patients
Wang et al. Blood pressure and left ventricular hypertrophy in patients on different peritoneal dialysis regimens
US20170281020A1 (en) Rapid Detection of Bleeding Following Injury
Chang et al. A quantitative real-time assessment of Buerger exercise on dorsal foot peripheral skin circulation in patients with diabetes foot
Middleton et al. Noninvasive hemodynamic monitoring in the emergency department
Senturan et al. The relationship among pressure ulcers, oxygenation, and perfusion in mechanically ventilated patients in an intensive care unit
Luo et al. Trendelenburg maneuver predicts fluid responsiveness in patients on veno-arterial extracorporeal membrane oxygenation
Günal et al. Blood pressure control and left ventricular hypertrophy in long-term CAPD and hemodialysis patients: a cross-sectional study
Chen et al. Can we improve the clinical utility of respiratory rate as a monitored vital sign?
US20220071551A1 (en) Method and system for pressure related skin injury risk assessment and treatment
Pipili et al. Changes in skeletal muscle microcirculation after a hemodialysis session correlates with adequacy of dialysis
Masterson et al. Using an alternating pressure mattress to offload heels in ICU
Tarzia et al. Cardiopulmonary exercise testing responses to different external portable drivers in a patient with a CardioWest Total Artificial Heart
Abouelwafa et al. The usefulness of veno-arterial extracorporeal membranous oxygenation in patients with cardiogenic shock
Moriya Changes in Prefrontal Cortical Oxygenation During Tilt Table Orthostatic Hypotension in Subarachnoid Haemorrhage Patients
Lind et al. Relations between mixed venous oxygen saturation and hemodynamic variables in patients subjected to abdominal aortic aneurysm surgery and in patients with septic shock
Tiba et al. Dynamic limb bioimpedance and inferior vena cava ultrasound in patients undergoing hemodialysis
US20210350927A1 (en) Assessing circulatory failure
US20220130550A1 (en) Method of obtaining advice data of physiological characteristics for a patient in order to lower risk of the patient entering a medical emergency state

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION